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ABSTRACT
The American College of Cardiology (ACC) and the American Heart Association (AHA) (2013;
2016), as well as the American Diabetes Association (ADA) joined forces to create clinical
practice guidelines (CPGs) recommendations for healthcare providers (HCPs) to follow with the
aim of preventing cardiovascular disease (CVD). Cardiovascular disease is the leading cause of
morbidity and mortality in the United States. The Centers for Disease Control (2017a) estimates
CVD costs 325 billion dollars annually. Although CVD has an astronomical cost associated with
it, CPG adherence continues to be an issue among HCPs and improvement is warranted. The
purpose of this EBP project was to alter standard practice among HCPs, with the aim of
improving adherence of CPGs through prescribing a statin and/or aspirin among patients who
have been diagnosed with dyslipidemia, hypertension (HTN), and/or type 2 diabetes mellites
(T2DM) and have a 10-year atherosclerotic cardiovascular disease (ASCVD) risk factor of
greater than or equal to 7.5%, thereby potentially preventing primary CVD in these at-risk
patients. The sample size (N = 3) included one physician and two nurse practitioners who have
prescriptive authority. Kotter’s change model was used as the theoretical framework and the
Promoting Action on Research Implementation in Health Services (PARiHS) model as the
evidence-based practice model used to guide this project. An extensive literature search was
performed, which generated 10 pieces of evidence that met the inclusion criteria for this EBP
project. The interventions for this project included a multi-modal approach that included four
strategies: (a) education, (b) computer-generated paper reminders, (c) visual cues and (d)
feedback. A cross tabulation Chi-square analysis was used to determine the effectiveness of the
four intervention strategies for improving adherence by HCPs with prescribing statins and/or
aspirin for the primary prevention of CVD in at-risk adult patients. Results showed HCPs
prescribed according to the CPGs for 59.4% (n = 139) of the patients. A combined statistically
significant improvement between all phases of this EBP project for compliance showed (X2 =
6.887, df = 2, p = 0.032).
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CHAPTER 1
INTRODUCTION
Clinical practice guidelines (CPGs) have been created as recommendations for health
care providers (HCPs) to follow to improve patient outcomes (Fox et al., 2015; Goff et al., 2013;
Stone et al., 2013). In 2013, the American College of Cardiology (ACC) and American Heart
Association (AHA) joined forces to create CPG recommendations to assess cardiovascular risk
(Goff et al., 2013) and to develop blood cholesterol treatment recommendations to reduce
ASCVD risks among adult patients (Stone et al., 2013). In 2015, the AHA and American
Diabetes Association (ADA) updated their CPG recommendations for the prevention of primary
and secondary cardiovascular events (Fox et al., 2015; Garza, Dols, & Gillespie, 2017; Goff,
2014; Stone et al., 2013). These guidelines were endorsed in 2016 by the United States
Preventive Services Task Force (USPSTF) (USPSTF, 2016). In 2017, several entities gathered
to create new recommendations for blood pressure parameters for the prevention of primary
CVD among at-risk adult patients (Whelton et al., 2018).
These CPGs recommend that patients who meet one of the following criteria:
1) Clinical ASCVD,
2) Primary elevations of LDL-C great than or equal to 190 mg/dl,
3) diabetes ages 40-75 years, with a LDL-C of 70-189 mg/dl and without clinical
ASCVD or
4) without clinical ASCVD or diabetes with a LDL-C 70-189 mg/dl and estimated 10
year ASCVD risk great than or equal to 7.5% using the Pooled Cohort Equation
(PCE) (Stone et al., 2013).
5) One or more CVD risk factor (i.e., dyslipidemia, hypertension (HTN), diabetes, or
smoking) and a 10-year estimated ASCVD risk factor great than or equal to 10%
using the PCE (USPSTF, 2016).
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6) Estimated ASCVD risk great than or equal to 10% using the PCE and systolic blood
pressure (SBP) great than or equal to 130 mm HG or diastolic blood pressure (DBP)
great than or equal to 80 mm HG (Whelton et al., 2018).
would benefit from initiating a moderate or high intensity 3-hydroxy-3-methyl-glutaryl-coenzyme
A reductase inhibitor (statin) (Fox et al., 2015; Stone et al., 2013) or aspirin (USPSTF, 2016).
However, prior to prescribing, HCPs must consider the risk of statin and aspirin therapy side
effects versus the benefits to patients. Although side effects exist, the benefits of statin therapy
outweigh the risks (Bender, 2014). Therefore, HCPs must overcome barriers and comply with
CPGs.
Unfortunately, HCPs do not always adhere to the evidence-based CPGs created
because of the following barriers: a) lack of knowledge (Jun, Kovner, & Stimpfel, 2016), b) too
time consuming to implement (Barth et al., 2016; McKee et al., 2017), c) the CPGs are too long
to read (Alexander, Li, Tonelli, & Guyatt, 2016), d) various recommendations (Barth et al.,
2016), and/or e) primary care physicians not having input into the creation of the CPGs
(Alexander et al., 2016). It is vital for HCPs to implement and adhere to CPGs to improve patient
outcomes (Barth et al., 2016; Hendrix, Downs, & Carroll, 2015; McKee et al., 2017). To
overcome barriers, strategies have been created which include: a) education (Jeffery et al.,
2015), b) audits and feedback (Ivers et al., 2012), c) reminders in electronic medical records
(EMR) (Garza et al., 2017; Shojania et al., 2009), d) computer-generated alerts (Arditi, RegeWalther, Durieux, & Burnand, 2017), e) paper prompts (Pantoja et al., 2014), and f) highlighted
reminders on paper (Hendrix et al., 2015). These strategies have and continue to be explored
to evaluate the best interventions for HCPs when implementing evidence-based CPGs into
practice.
Doctor of nursing practice (DNP) prepared nurses have the unique opportunity to assist
physicians and other HCPs in evaluating up to date evidence-based practices (EBPs) to utilize
when providing care to patients. Doctor of nursing practice prepared nurses are positioned to
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create and adopt strategies to assist physicians with implementing CPGs, thereby improving
patient outcomes. Because the prevalence and cost of treating CVD is at a record high in the
United States (Healthy 2020, 2014), it is essential that DNP prepared family nurse practitioners
(FNPs) have knowledge to recognize and treat the signs and symptoms of CVD. Family nurse
practitioners must stay abreast of current evidence to prevent primary CVD in at-risk adult
patients and follow the recommended guidelines while treating each patient as a unique
individual.
Background
In the United States, CVD costs $325 billion annually (Healthy People 2020, 2014) and
is the leading cause of morbidity and mortality regardless of race, ethnicity, or gender (Centers
for Disease Control [CDC], 2017a; Healthy People 2020, 2014; National Heart, Lung, and Blood
Institute [NHLBI], 2017). Therefore, a goal of Healthy People 2020 (2014) is to:
Improve cardiovascular health and quality of life through prevention, detection, and treatment
of risk factors for heart attack and stroke; early identification and treatment of heart attacks
and strokes; prevention of repeat cardiovascular events; and reduction in deaths from
cardiovascular disease (Healthy People 2020, 2014).

Cardiovascular disease is an umbrella term, which includes heart disease and coronary
heart disease (CHD) (NHLBI, 2017). Heart disease affects the structure and function of the
heart (NHLBI, 2017) and can cause strokes, congenital heart defects, and peripheral artery
disease (NHLBI, 2017). Hypertension, dyslipidemia, diabetes, smoking, excessive alcohol
intake, obesity, unhealthy eating habits, sedentary lifestyle, age, and family history are all risk
factors that contribute to primary CVD (CDC, 2012, 2017a; Healthy People 2020, 2014). It is
essential that HCPs adhere to evidence-based CPGs to achieve primary prevention of CVD to
reduce costs and improve patient outcomes.
According to Fox et al. (2015), preventing primary CVD involves the proper management
of five key components: (a) nutrition, (b) obesity, (c) blood glucose, (d) blood pressure, and (e)
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cholesterol. Patients and HCPs must work collaboratively towards the following three goals: (a)
maintain a hemoglobin A1C of less than or equal to 6.5%, which has been recommended as an
acceptable level by the ADA, (b) maintain a SBP of less than or equal to 130 with a diastolic
blood pressure (DBP) of less than or equal to 80, which has been noted as an acceptable level
by the 8th Joint National Committee (JNC 8) Hypertension Guidelines (Whelton et al., 2018), and
(c) maintain a low-density lipoprotein-cholesterol (LDL-C) of less than 70 mg/dl, which is based
on the 2013 ACC and AHA guidelines (Fox et al., 2015; Stone et al., 2013).
According to Bender (2014), it is unrealistic to think HCPs alone can combat chronic
patient illnesses. Healthcare providers must educate adult patients, who are at-risk for primary
CVD, about lifestyle modifications (i.e., obesity, weight loss, heart healthy diet, exercise, and
smoking cessation) which are crucial to preventing primary CVD (Fox et al., 2015; Goff et al.,
2013; Jensen et al., 2014; Stone et al., 2013). While education can assist in improving patient
awareness, patients must take the initiative to modify their lifestyles (Fox et al., 2015; Jensen et
al., 2014).
Obesity is a major modifiable risk factor for dyslipidemia, HTN, T2DM, and CVD (Jensen
et al., 2014). Therefore, it is critical to educate individuals who are overweight, with a body mass
index (BMI) of 25.0 to 29.9 kg/m2 or obese with a BMI greater than 30 kg/m2, to alter their
lifestyles to that of a heart healthy lifestyle because they are at a higher risk for morbidity and
mortality (Jensen et al., 2014). Weight loss can be achieved by eating a healthy diet and
incorporating intense exercise into one’s routine or through diet, medication, meal replacement,
or bariatric surgery (Fox et al., 2015; Jensen et al., 2014).
Modifying one’s diet is another strategy that can aid in reducing one’s risk of CVD. The
Mediterranean Diet, Dietary Approaches to Stop Hypertension (DASH) diet, and the American
Heart Association diet are diets recommended by CPGs to decrease risk factors for morbidity
and mortality (Eckel et al., 2014; Fox et al., 2015). Consuming a low-salt, low-fat, low
carbohydrate diet with increasing one’s fruit, vegetables, legumes, and whole grains intake
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effectively improves blood glucose levels, blood pressure, and lipid levels (Eckel et al., 2014;
Fox et al., 2015; Jensen et al., 2014; Stone et al., 2015).
Exercise is an essential strategy for preventing primary CVD among at-risk adult patients
(Fox et al., 2015). Intense physical activity, which occurs three or more times per week, for at
least 40 minutes has aided in reducing one’s weight, waist circumference, blood glucose levels,
lipid levels, and blood pressure (Fox et al., 2015; Jensen et al., 2014). Physical activity must be
incorporated alongside a healthy diet to prevent CVD among at-risk adult patients (Fox et al.,
2015).
Smoking tobacco is another modifiable risk factor associated with CVD (CDC, 2017a;
Fox et al., 2015). Adult patients who quit smoking tobacco, though gain weight, have a greater
chance of preventing primary CVD than individuals who continue smoking tobacco (Fox et al.,
2015).
Although these risk factors are modifiable, individuals are generally not inclined to
change their behavior to become healthier (Bender, 2014). Even with lifestyle modification,
some patients remain at-risk for CVD and require pharmacological interventions to prevent
dyslipidemia, HTN, and T2DM (Fox et al., 2015). Therefore, several strategies have been
published to remind HCPs to implement CPG recommendations and have included: (a) using
audit and feedback techniques (Ivers et al., 2012; Li, 2018), (b) utilizing computer-generated
paper reminders (Arditi et al., 2017), (c) implementing electronic medical record alerts (Garza et
al., 2017; Hendrix et al., 2015; Shojania et al., 2009), (d) incorporating manual paper prompts at
point of care (Pantoja et al., 2014), and (e) using clinical decision support systems (CDSS) (Fiks
et al., 2015; Rokstad, Rokstad, Holmen, Lehmann, & Assmus, 2013; Zahanova, Tsouka,
Palmert, & Mahmud, 2017).
Statement of the Problem
Clinical practice guidelines are evidence-based recommendations created to assist
HCPs when making decisions to improve patient outcomes (Goff et al., 2013; Fox et al., 2015,
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Stone et al., 2013; Whelton et al., 2018). Unfortunately, evidence shows that barriers prevent
HCPs from following CPGs. Common barriers that impact HCPs adherence to CPGs include:
(a) lack of knowledge, (b) the length of CPGs, (c) the time consuming nature of CPG
implementation, (d) the fact that primary care physicians (PCPs) are not always involved in
creating CPGs, (e) the age of the provider, and (f) disagreement with CPGs (Alexander et al.,
2016; Barth et al., 2016; Jun et al., 2016; McKee et al., 2017). It is vital that HCPs are willing to
accept and adhere to guidelines set forth by the governing bodies to prevent CVD among at-risk
adult patients. Healthcare providers must become knowledgeable of the evidence available and
be receptive to new and improved patient treatment options.
Morbidity and mortality rates increase among patients who have been diagnosed with
CVD (CDC 2012, 2017a). Therefore, it is essential that all precautions are taken to assure
primary CVD is prevented among at-risk adult patients. The initial focus of lifestyle changes
must be patient education to prevent CVD, which includes education about obesity, weight loss,
heart healthy diet, exercise, and smoking cessation (Fox et al., 2015; Stone et al., 2015).
Patients are not always compliant with the education received from HCPs (Bender, 2014). As a
result, HCPs are inclined to initiate statin and/or aspirin therapy for the primary prevention of
CVD in at-risk adult patients.
Data from the Literature Supporting Need for the Project
Although the ACC/AHA teamed up to create CPGs, HCPs are not adhering to these
developed CPGs (Goff et al., 2013, Fox et al., 2015; Stone et al., 2013). Physician barriers for
not adhering to CPGs include: (a) lacking input in regard to the creation of CPGs, (b) a weak
level of evidence when forming the CPGs, (c) lacking clarity, (d) length of the CPGs, (e)
ambiguity of the CPGs (Alexander et al., 2016), (f) content disagreement, (g) unaware or lack
familiarity of the CPGs, (i) inadequate time associated with implementing CPGs, and lacking
resources (Barth et al., 2016). Healthcare providers who adhere to recommended CPGs have
noted better patient outcomes (Barth et al., 2016; Hendrix et al., 2014; Jun et al., 2016; McKee

6

PREVENTING PRIMARY CVD: CPG COMPLIANCE

7

et al., 2016). Registered nurses express similar barriers for not adhering CPGs as those
denoted by physicians, which include: (a) attitudes and perceptions, (b) motivation, cultural
differences, (c) reluctance, (d) no benefit, (e) knowledge, (f) usability, (g) not easily accessible,
(h) format and content, (i) conflicting evidence, (j) many without goals, (k) clarity or direction,( l)
conflicting with physician’s practices, (m) time, (n) workload, (o) equipment, (p) leadership
support, and (q) the culture of the organization (Jun et al., 2016; McKee et al., 2017).
Several strategies have been published regarding how to implement CPGs into practice.
Researchers have noted that the following techniques have been beneficial in improving patient
CPG adherence: (a) audit and feedback (Ivers et al., 2012), (b) computer-generated reminders
delivered on paper (Arditi et al., 2017; Garza et al., 2017), (c) paper reminders with highlights
(Hendrix et al., 2015), (d) EMR prompts (Garza et al., 2017; Hendrix et al., 2015), (e) on screen
point of care reminders (Shojania et al., 2009), and (f) manual paper reminders (Pantoja et al.,
2014).
Garza et al. (2017) conducted a quality improvement project that sought to improve
primary prevention of CVD among adults with T2DM. The researchers created alerts in the EMR
system that alerted HCPs for adults with and without complicated T2DM who had never had a
cardiovascular event to follow CPGs. The alert system opened the PCE to calculate a patient’s
10-year ASCVD risk factor for HCPs to complete if one had not been completed within the last 5
years. The EMR alert system improved CPG compliance through initiating a statin or an aspirin
regimen, as well as educating patients about the importance of healthy diet and exercise (Garza
et al., 2017). The authors noted that alert systems work when the systems are properly utilized,
stakeholders are involved and agree with changes, and individuals work as team players.
Data from the Clinical Agency Supporting Need for the Project
Upon providing care for patients in an urban Midwest community clinic, the Project
Leader (PL) noted that at-risk patients were not being treated with proper medications to
prevent primary CVD. A pilot audit of 100 patient charts showed that 63 patients who attended
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point of care visits within the past 2 years and who met the criteria recommended by the
ACC/AHA, AHA/ADA, and the USPSTF were not prescribed a statin or aspirin to prevent to
prevent primary CVD. Given the information available to the PL, it was unclear if the lack of
adherence of HCPs to CPG recommendations was due to lack of knowledge about CPGs
among HCPs, ambiguity about CPGs, the time constraints associated with implementing CPGs,
or that HCPs were too comfortable their current medical practices. Furthermore, laboratory
findings revealed that many patients who were 40 to 75 years of age had a LDL-C of 70 mg/dl to
189 mg/dl, elevated or stage 1 hypertension, T2DM, smoked, and/or were obese, thus
confirming that screenings were not properly conducted nor were strategies implemented to
prevent primary CVD. Some patients, ages 40 to 75, did not have a baseline lipid panel ordered,
which is problematic because lipid panels can alert HCPs to patients who have dyslipidemia,
are at risk for primary CVD, and require statin initiation. Furthermore, patients who did have a
lipid panel ordered did not follow up with testing.
The PL observed that HCPs, at the project site, did not utilize the PCE to evaluate
patients’ 10-year ASCVD risk factors. This failure to use the PCE is concerning because
patients need to be initiated on a moderate or high dose statin and/or aspirin, as noted by the
current CPGs (Fox et al., 2015; Stone et al., 2013). In addition to lacking CPG implementation,
the PL observed that there was no mechanism in place for reminding HCPs to identify adult
patients at-risk for primary CVD. While the facility uses an EMR system, there was no reminder
system in place for HCPs to perform the PCE to evaluate if patients need a statin and/or aspirin
initiated. After communicating with information technology staff members, the PL found that the
facility was not able to implement an electronic reminder in the EMR for this medical practice
because of interference throughout the enter hospital system.
Finally, the facility began receiving notifications from insurance companies that reminded
HCPs to initiate statin therapy for T2DM patients. Therefore, the initial focus of this EBP project
shifted from patients diagnosed with T2DM to all patients at-risk (such as those who have
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dyslipidemia, HTN, and/or T2DM) for prevention of primary CVD. Broadening the population to
include patients who had a diagnosis of dyslipidemia and HTN was also warranted based on the
data collected during the pilot.
Purpose of the Evidence-Based Practice Project
The purpose of this EBP project was to alter standard practice among HCPs by
improving their adherence to CPGs by prescribing a statin and/or aspirin among patients who
have been diagnosed with dyslipidemia, HTN, and/or T2DM and have a 10-year ASCVD risk
factor of greater than or equal to 7.5%. Changing practice to conform to CPGs potentially
prevents primary CVD in these at-risk patients. It is imperative that HCPs take the time to utilize
the PCE, which is available through the AHA or ACC website or for download to their mobile
device, to ensure ease of equation access. Through using the PCE, HCPs can estimate 10-year
ASCVD risk factors among patients, as well as educate adult patients about lifestyle
modification to assist in preventing primary CVD.
Compelling Clinical Question
The compelling clinical question that guides this study is, “What is the best intervention
to implement for HCPs to adhere to CPGs, so at-risk adult patients will be prescribed a statin
and/or aspirin in accordance with the ACC/AHA AHA/ADA CPGs and USPSTF
recommendations?” The decision to adhere to the CPGs must be made by evaluating a
patient’s modifiable and non-modifiable risk factors, assessing patients estimated 10-year
ASCVD risk factor (through utilizing the PCE), evaluating patients’ allergies, risk of side effects
versus benefit of initiating a statin and/or aspirin, and a collaborative agreement among the HCP
and patient.
PICOT Question
The PICOT question that guided this study is, “For healthcare providers in a primary
care setting, does incorporating a multi-modal approach that involves education, using
computer-generated paper reminders at point of care, visual cues, and ongoing feedback about
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prescribing performance improve the initiation of medication therapy for the prevention of
primary CVD in at-risk adult patients over a 7-week period?”
Significance of the EBP Project
It is imperative that HCPs move evidence into practice by implementing strategies that
remind them to initiate a statin and/or aspirin for at-risk patients. Electronic medical record alerts
(Garza et al., 2017; Shojania et al., 2009), audits and feedback (Ivers et al., 2012; Li, 2018),
education (Jeffery et al., 2015), computer-generated paper alerts (Arditi et al., 2017), manual
paper reminders (Pantoja et al., 2014), highlighting prompts on paper reminders (Hendrix et al.,
2015), and CDSS (Fiks et al., 2015; Rokstad et al., 2013; Zahanova et al., 2017) are a few
strategies that can be implemented to ensure CPG compliance by HCPs. Healthcare providers
who utilize strategies to implement CPGs have noted improved patient outcomes (Fox et al.,
2015; Goff et al., 2013; Stone et al., 2013).
Through determining the best evidence-based practices, this doctoral EBP project had
the potential to improve HCP adherence to the guidelines set forth by the ACC/AHA (2013,
2018), the AHA/ADA (2015), and the USPSTF (2016). The aforementioned guidelines
recommend that patients who are 40 to 75 years old and have an estimated 10-year ASCVD
risk factor greater than or equal to 7.5, an LDL-C of 70-189 mg/dl, a SBP greater than or equal
to 130, and a DBP greater than or equal to 80 should be started on a statin and/or aspirin
regimen (Fox et al., 2015; Stone et al., 2013; USPSTF, 2016; Whelton et al., 2018). Every 5
years, a patient’s ASCVD should be calculated using the PCE, which is available through the
ACC and AHA websites, as well as available for download using one’s mobile device (Goff et
al., 2013; Stone et al., 2013). The prevention of primary CVD among at-risk adult patients aligns
with the goals expressed by Healthy People 2020 (2014). Additionally, DNP prepared nurses
are in a unique position to implement strategies to assist HCPs stay abreast of CPGs.
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CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
Evidence-based practice, theory, and EBP models are fundamental aspects of to the
practice of DNP prepared nurses because these aspects work together to guide practice.
Evidence-based practice is essential for changing practice to obtain the best possible patient
outcomes. The PL believes that through implementing this DNP project, a culture of change can
occur from current practice by HCPs to a culture in which HCPs adhere to prescribing or statins
and/or aspirin so that patient outcomes can improve. The incorporation of CPGs can assist in
preventing primary cardiovascular disease among adult patients who have identified risk factors
(i.e., dyslipidemia, HTN, and/or T2DM) (Fox et al., 2015; Stone et al., 2013).
The PICOT question that guided this EBP project reads, “For healthcare providers in a
primary care setting, does incorporating a multi-modal approach that involves education, using
computer-generated paper reminders at point of care, visual cues, and ongoing feedback about
prescribing performance improve the initiation of medication therapy for the prevention of
primary CVD in at-risk adult patients in a 7-week period?”
Theoretical Framework
There are various theoretical frameworks that nurses can use to guide evidence-base
projects. For example, nurses are introduced to nursing theory in undergraduate nursing
baccalaureate programs. Nursing schools often utilize a theoretical framework to guide nursing
curriculum. Nurses can focus the care that they provide to patients using a theoretical
framework. Oftentimes, DNP prepared nurses are well versed about theories and use them to
guide EBP projects. The selected theory must be the best choice for the population,
environment of focus, and goal of the EBP project.
Overview of Theoretical Framework
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After researching various change models, which are well respected in the field of
nursing, the PL realized that Kotter’s 8-step change model (Kotter, 1995, 1996, 2012) best
aligned with this EBP project’s purpose. Kotter (1995) initially wrote about his change model in
Harvard Business Review. Although, the 8-step change model is often applied in organizations,
this model can work well when making changes to HCPs daily practice. For example, Mork,
Krup, Hankwitz, and Malec (2017) utilized Kotter’s change theory to create change efforts
regarding handoff communication among nurses in an intensive care unit. Small et al. (2016)
performed the same quality improvement project as Mork et al (2017), on a surgical orthopedic
trauma unit, where 96% of patients and 86% of nurses were satisfied with the changes made
regarding handoff communication. Mork et al. stated that with stakeholders, directors, and
managers being onboard with the changes to handoff communication, the change was
successful. Kotter’s change framework has been utilized to implement change in a football for
health program (Langton, Khan, & Lusina, 2010), transforming library services (Wheeler &
Holmer, 2017), and for integrated care communities (Bradbury, 2014). The 8-step plan is easy
to follow and adaptable to any environment (Mork et al., 2017).
Kotter’s (1996, 2012) 8-step change model includes three phases and 8-steps. Phase
one is the defrost phase which consist of steps 1-4 which is when the transformation process is
occurring, phase two which is the introduction and implementation of the change which includes
steps 5-7, and phase 3 includes steps 8 which is anchoring the change by making the change
permanent. Kotter explained that each step of the model must be completed for successful
change to occur. Kotter (1996, 2012) continues to explain that prior steps must be reinforced
when issues arise while moving to the next step. The steps for the 8-step change model include:
1) establishing a sense of urgency,
2) creating the guiding coalition,
3) developing a vision and strategy,
4) communicating the change vision,
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5) empowering broad-based action,
6) generating short term wins,
7) consolidating gains and producing more change, and
8) anchoring new approaches in the culture (Kotter, 1996, p. 21).
The PL selected Kotter’s model of change because organizational change needed to occur in
the selected project location. The PL recognized the critical nature of organizational change,
specifically among HCPs who were not following CPGs. The CPG process implemented
involved prescribing a statin and/or aspirin in patients who had a diagnosis of dyslipidemia,
HTN, and/or T2DM, as well as a 10-year ASCVD risk factor of greater than or equal to 7.5%.
The goal of this project was to implement strategies to facilitate HCPs prescribing a statin and/or
aspirin to prevent primary CVD among at-risk adult patients.
Application of Kotter’s Framework to EBP Project
Establishing a sense of urgency entails identifying problems within the organization
(Kotter, 1996, 2012). Preventing primary CVD in T2DM patients was established as a priority for
patients who were being provided care in the urban walk-in clinic in which this project was
conducted. A pilot chart audit was performed to establish feasibility for the project. Based upon
the results of the pilot chart audit, it was determined that HCPs were not prescribing statins
and/or aspirin to at-risk patients who had a 10-year ASCVD score great than or equal to 7.5%.
Therefore, the focus of this project was broadened to preventing primary CVD in at-risk adults
including those who had a diagnosis of dyslipidemia, HTN, and T2DM.
The second step of Kotter’s change model involves creating the guiding coalition, which
entails determining individuals who can lead the coalition for change, as well as encouraging
teamwork among group members (Kotter, 1996, 2012). The project leader encouraged
teamwork among the medical assistants and the office manager, thus enhancing the EBP
project’s likelihood of success. The project leader asked the medical assistants to lead the
coalition and to ensure that the PCE was being completed and printed. Furthermore, the office
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manager was asked to assure the paper reminders were placed in the examination rooms so
the HCPs would refer to them when prescribing a statin and/or aspirin for at-risk patients.
The third step in Kotter’s change model (Kotter, 1996, 2012) involves developing a vision
and strategy. For this project, the third step of Kotter’s model was utilized by ensuring that key
stakeholders were educated about strategies that could enhance CPG compliance about
prescribing a statin and/or aspirin in patients who had a diagnosis of dyslipidemia, HTN, and/or
T2DM and had a 10-year ASCVD risk factor of greater than or equal to 7.5%. During the first
week that this project began, the PL was in the office each day. The PL educated the office
manager and medical assistants regarding how to properly perform the PCE to calculate a
patient’s 10-year ASCVD risk factor.
Step four in Kotter’s change model involves communicating the change vision to key
organizational stakeholders. Specifically, this process involved educating and communicating
the project’s vision and strategies to all participants, as well as reiterating the vision to
organizational stakeholders (Kotter, 1996, 2012). A PowerPoint presentation was presented to
HCPs, medical assistants, and the office manager regarding the fact that HCPs were not
prescribing statins or aspirin to prevent primary CVD in at-risk patients. The PL provided an
educational session about the national statistics for CVD mortality. Additionally, pilot chart audit
data were provided to all HCPs. Education about the 2013, 2015, and 2018 CPGs were
discussed and details regarding the 10-year ASCVD risk calculator were provided, thereby
ensuring comprehension among participants. Additional education was provided to the medical
assistants and the office manager regarding where the PCE was located. When providing
information about the PCE, a see one, do one, teach one approach was utilized. To remind
HCPs about CPGs, a visual cue (flowsheet) (Appendix B) was placed in each examination
room.
The fifth step begins phase two in Kotter’s change model which involves empowering
broad-based action. This step ensures that obstacles are removed, specifically those that will
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hinder change from occurring (Kotter, 1996, 2012). To carry out this step, education about
CPGs was provided to HCPs, medical assistants, and the office manager. The HCPs were
informed that they would receive each patient’s ASCVD risk factor percentage. Based on the
ASCVD percentage and a patient’s diagnosis of dyslipidemia, HTN, and/or T2DM, HCPs were
asked to recommend that patients start on a moderate or high dose statin, an aspirin, or both
treatment regimens. The PL provided step-by-step instructions to the medical assistants and the
office manager regarding the online location of the AHAs and ACCs PCE. Furthermore, the PL
demonstrated to the medical assistants and office manager what information belonged in each
category of the PCE to calculate at-risk patients’ 10-year ASCVD risk factor and showed
individuals how calculation results would appear. These results were printed out and the
patient’s identification number was written in the top right-hand corner, thereby revealing whose
ASCVD risk factor percentage was obtained without providing any identifying demographics. To
ensure anonymity, no patient information was saved on the computer nor kept on the calculator.
The computer-generated reminder was printed out then placed in the examination room with the
patient. The PL showed the medical assistants and office manager where to place the printed
calculation form so HCPs would notice the printed 10-year ASCVD risk factor calculation. The
form provided details to HCPs regarding if a patient needed or did not need the statin or aspirin
intervention. The PL asked the medical assistants and office manager to return the printed PCE
calculation to the front desk and place it in a manila folder.
Step six of Kotter’s change model involves generating short-term wins. These short-term
wins consist of visibility, unambiguousness, and clarity and are related to the change effort
(Kotter, 1996, 2012). Kotter (1996, 2012) stated that the roles of short-term wins are to: (a)
provide evidence that sacrifices are worth it, (b) reward change agents with a pat on the back,
(c) help fine-tune vision and strategies, (d) undermine critics and self-serving resisters, (e) keep
bosses on board, and (f) build momentum. To accomplish short-term wins, the PL conducted
weekly audits of five charts over the 7-weeks during which this project was conducted. Monthly
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lunches were also provided, by the PL, to the HCPs during the times project members met to
discuss the project. During these meetings, the PL and project participants discussed
adherence or nonadherence to CPGs. Additionally, the PL provided feedback, as needed, to
ensure project success. However, the medical assistants and office manager received a positive
verbal gesture along with monthly lunches for performing the PCE calculations and providing
the printed reminders for the HCPs to locate and intervene on at-risk patients.
Step seven in Kotter’s (1996, 2012) change model involves consolidating gains and
producing more changes. To ensure that changes are made, the change process must
continue, and a sense of urgency and momentum must be established. It is important to note
when short-term wins are accomplished (Kotter, 1996, 2012). For this project, the PL
acknowledged and displayed appreciation for the progress being made by the medical
assistants and office manager, specifically in terms of thanking these individuals for supplying
HCPs with patients’ 10-year ASCVD risk factor calculations. Furthermore, the PL provided
positive feedback to HCPs as they continued to change their daily practice by adhering to CPGs
by prescribing a statin and/or aspirin in patients who have a diagnosis of dyslipidemia, HTN,
and/or T2DM and a 10-year ASCVD risk factor greater than or equal to 7.5%. Additionally, the
PL informed all stakeholders of the goal of this EBP project, which involved 100% of patients
who were diagnosed with dyslipidemia, HTN, and/or T2DM and demonstrated a 10-year
ASCVD risk calculation of greater than or equal to 7.5% being started on a statin and/or an
aspirin regimen.
The final step is phase three of Kotter’s change model involves anchoring new
approaches in the culture by making change permanent within an organizational culture (Kotter,
1996, 2012). The success of this step depends on results, requires a great deal of conversation,
may result in turnover, and involves decisions regarding succession planning. Organizational
change can be a slow and tedious process, which is often difficult since individuals are
accustomed to their normal routines. To ensure that the change was successfully implemented,
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the project leader assisted with the PCE, as necessary; however, this assistance was not
habitual. Feedback regarding the results provided to the HCPs during the pre-intervention,
implementation, and post-intervention phases of this project.
Strengths and Limitations of Theoretical Framework for EBP Project
Several organizations have utilized Kotter’s 8-step change model (Bradbury, 2014;
Langton et al., 2010; Mork et al., 2017; Small et al., 2016; Wheeler & Holmer, 2017) since its
inception. In 1995, the model was updated and published. Kotter’s 8-step change model is
highly regarded by organizational development practitioners, scholars, and change agents. The
8-step change model has been used in businesses, as well as within healthcare organizations,
thus reinforcing the model’s applicability regardless of industry/setting.
One of the limitations of this model is that all eight steps had to be completed to ensure
a successful change effort. Steps can be reinforced as one moves forward to other steps;
however, steps could not be skipped, overlooked, or rushed (Kotter, 1996, 2012). This approach
is not always compatible with the culture of the United States because rapid changes are
preferred. Furthermore, the culture was not open to many change initiatives, thus adding to the
stressors of deviating from the status quo. This model was too difficult to use given the short
timeframe of this study. Although the PL believed that this model was best to ensure that
organizational change occurred, it proved to be challenging in the clinical setting.
Evidence-based Practice Model
Evidence-based practice models are used to guide the implementation of an EBP
project. Doctor on nursing practice prepared nurses are educated about several types of EBP
models; therefore, these individuals can choose the best model for projects. Each model is
different and should be carefully assessed and evaluated prior to model implementation.
Overview of EBP Model
The project leader chose to use the promoting action on research implementation in
health services framework (PARiHS) as the EBP model for this project. The PARiHS framework
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includes three elements. Each of the elements has sub-elements. Kitson, Harvey, &
McCormack (1998) proposed that implementing research into practice is a function (f) and that
evidence (E), context (C), and facilitation (F) should be considered simultaneously. The formula
created for the framework to ensure successful implementation is (SI) = f(E, C, F) (Kitson et al.,
1998). All elements must be given equal time and energy, because each element is equally
important when implementing evidence into practice.
Evidence can be obtained from various sources and is advantageous in several settings.
To ensure the quality of evidence, ratings are provided. An example of high-level evidence is
the use of randomized control trials (RCT) (Kitson et al., 1998). An example of low-level
evidence is the use of descriptive opinion statements (Kitson et al., 1998). Regardless of the
level of evidence, if the HCP and the patient agree to the evidence provided, that evidence will
guide the changes implemented.
The context, as represented in the formula above, is related to the setting where the
implementation of the evidence will occur (Kitson et al., 1998). The context plays a major role in
the successful implementation of a change effort. The sub-elements to help with the context are
culture, leadership, and evaluation (Kitson et al., 1998; Melnyk & Fineout-Overholt, 2015).
Facilitation consist of the individuals who support and encourage one another throughout
the implementation process (Kitson et al., 1998). Change is not an easy process and individuals
are often hesitant of change efforts. Thus, a team effort is needed to support, encourage, and
provide understanding regarding the desired outcomes associated with the change being
implemented. Kitson et al. (1998) noted that open dialogues about roles, being open-minded,
and changing one’s thought process can facilitate a change effort.
Application of EBP Model to EBP Project
For this EBP project, the PL applied the PARiHS framework by obtaining high-level
evidence from peer-reviewed literature to support the implementation of CPGs into practice by
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HCPs. The evidence used in this project was appraised and the quality was graded. Only high
and good quality evidence was used in this project.
The context for this EBP project was an urban outpatient walk-in clinic. When this project
began, the PL realized that CPGs were not followed by the HCPs. Therefore, the PL provided
education to all individuals who were involved in this EBP project, thus ensuring understanding
of the requirements, the purpose of the project, etc. Furthermore, when questions arose, the PL
answered questions accordingly. To ensure successful project implementation, the PL
emphasized the importance of teamwork to improve patient outcomes.
The PL supported the medical assistants throughout the facilitation of this EBP project.
The PL assured the medical assistants were completing the PCEs for at-risk patients and the
computer-generated reminders were placed in examination rooms. The computer-generated
reminders alerted HCPs initiate a statin and/or aspirin for the prevention of primary CVD at point
of care visits. The project leader was available to HCPs and medical assistants for questions
regarding the PCE calculation, the 10-year ASCVD risk factor for primary CVD, and which
intensity of medication should be prescribed based on the patient’s risk factor.
Strengths and Limitations of EBP Model for EBP Project
The PARiHS framework was selected because its focus involves moving evidence to
practice. Kitson et al. (1998), the creators of PARiHS, provided three core values to help guide
the implementation process which are evidence, context, and facilitation. The PARiHS
framework has been refined, since inception, and has face validity, content validity, and
construct validity (Kitson et al., 1998; Rycroft-Malone et al., 2004). While there are various
strengths associated with PARiHS, limitations also must be explored. As previously noted,
HCPs are accustomed to their normal practice, therefore utilizing the PARiHS framework
changes the workflow for HCPs. Before this project was implemented, the PL realized that
HCPs may experience barriers (i.e., not agreeing with the intervention/approach) when using
CPGs to prevent primary CVD in at-risk patients.
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Literature Search
Evidence-based practice is an essential component of DNP preparation and to the
discipline of nursing. Doctor of nursing prepared nurses are expected to keep abreast about
new evidence, thereby ensuring that the highest quality of care is provided to patients. As
primary care providers, DNPs must also be prepared to implement EBP projects that can assist
in the improvement of patient care outcomes. To ensure that the best evidence is utilized, DNPs
need to conduct thorough literature reviews. Through utilizing timely, high-quality, and highly
cited sources, DNPs can ensure that they are utilizing highly regarded EBPs. Conducting a
saturated search of literature is a vital task for DNPs.
Sources Examined for Relevant Evidence
For this project, the PL performed a saturated search to find the most relevant evidence
for preventing primary CVD in at-risk patients. The focus of the literature search was to locate
evidence that discussed strategies to alert, prompt, or remind HCPs to comply with CPGs. The
PL gathered the highest level and best quality of evidence, using several databases, to support
this EBP project. The PL utilized various search strategies and databases to ensure that all
literature was explored. The Cumulative Index to Nursing and Allied Health Literature (CINAHL),
Cochrane, Joanna Briggs Institute (JBI), Medline, and the Nursing and Allied Health were
thoroughly explored. Duplicate pieces of evidence were eliminated. The Preferred Reporting
Items for Systematic Reviews and Meta-analyses (PRISMA) process is summarized in Figure
2.1.
The inclusion criteria used by the PL consisted of evidence that discussed alert,
reminder, prompt, or decision support systems. General practitioners, primary care providers,
and ambulatory/outpatient/hospital settings were also included. Evidence included in this project
involved studies that have been published within the past 5 years (2013-2018). An exception of
this timeline was made for two pieces of evidence, which were collected during the citation
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chase. Evidence was excluded that solely focused on patient reminders, patient adherence, and
bedside nursing reminders and adherence.
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Figure 2.1. PRISMA flow chart of Literature Review

Identification

Database searches

Keywords: “decision support system”, “reminder system”,
provider, practitioner, physician, “healthcare provider”,
and doctor
English language, Peer reviewed, published from 20132018,
databases: CINHAL, Cochrane, Joanna Briggs Institute,
Medline, Nursing and Allied Health

Citation Chase
(n=3)

Screening

(n=373)

Record after duplicates removed

Records excluded after review
of title and abstract

(n=363)

(n=213)

Records screened

Eligibility

(n=150)

Full text articles assessed for
eligibility
(n=53)

Full text articles excluded with
reason
• Evidence published prior to
2013; except for 2 citation
chased
• Evidence that were not
inclusive of physicians
• Evidence only specific to
hospital adherence
• Low quality evidence
• Inconsistent findings
• Poor generalizability

Included

(n=140)

Studies included in the literature
review
(n=10)
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The CINAHL database search yielded 76 pieces of evidence. The initial search of
CINAHL database involved the following search keywords: decision support system, clinical,
and technique. This initial search yielded 1,266 pieces of evidence. The next CINAHL heading
reminder systems with the Boolean operator OR between each which yielded 1,501 pieces of
evidence. The next line search consisted of the following keywords: provider, practitioner,
physician, healthcare provider, and doctor. These keywords yielded 352 pieces of evidence.
With 352 pieces of evidence, additional Boolean operators (AND and OR) were utilized.
Furthermore, quotations around two or more words and phrases, as well as an asterisk for
truncation led to the discovery of more evidence. The PL added a third line of keywords, which
resulted in a more succinct search. The keywords used during the third line of keywords search
included: guideline, protocol, practice guideline, and clinical practice guideline. This final step in
the search process resulted in the discovery of 76 pieces of evidence. The PL limited the
CINAHL database search to articles that were published from 2013 to 2018, were in
scholarly/peer-reviewed journals, and were written in the English language.
A search of the Cochrane database yielded 71 results. The keyword that was used in the
initial search was: reminder system. The second search included the keyword decision support
system and included the Boolean operator OR between both keywords. This search resulted in
73 articles. During the third search, other keywords utilized included: provider, practitioner,
physician, healthcare provider, and healthcare professional. During this step in the process, the
Boolean operator AND was added to the beginning of the search and the Boolean operator OR
was placed between each keyword. Quotations were placed around keywords with two or morewords phrases. The final addition of the keywords yielded 71 results. The limiters used when
searching the Cochrane database included articles that were published from 2013 to 2018 and
Cochrane Reviews.
The Medline database was searched, and 80 pieces of evidence were located. The
initial medical subject headings (MeSH) searched used the term “reminder systems,” which
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yielded 680 pieces of evidence. The second MeSH heading used included the term “decision
support systems.” When using the term “decision support systems,” the PL added a Boolean
operator OR between each MeSH heading, thereby yielding 6,636 pieces of evidence.
Keywords added to this search included: doctor, nurse, clinician, physician, practitioner,
healthcare professional, and healthcare provider, thus yielding 1,726 results. All keywords had
the Boolean operator OR between each keyword, the Boolean operator AND between each line,
and an asterisk was added for truncation to yield the most results. The PL then added another
line, which began with the Boolean operator AND. Furthermore, other keywords used included:
guideline, protocol, practice guideline, and clinical practice guideline. This step yielded 406
pieces of evidence. A final line of key phrases was added to this search and began with the
Boolean operator AND. In the final line, keywords included: primary care, family practice, and
physician office, thereby yielding 80 pieces of evidence. All keywords had the Boolean operator
OR between each and each line began with the Boolean operator AND. Phrases with two or
more-words phrases were placed in quotation marks, so the database did not separate the
words during the search. The limiters used when searching the Medline database included
articles that were published from 2013 to 2018 and articles written in the English language.
The Nursing and Allied Health database was also searched and yielded 120 results
during the final search. The keyword utilized with MeSH headings included “reminder systems,”
thereby yielding 18 pieces of evidence. Decision support systems MeSH headings were added
to the search and resulted in 155 pieces of evidence. All MeSH headings had the Boolean
operator OR between each heading. The PL added another line with the Boolean operators
AND at the beginning of each line, as well as OR between each keyword. During the third
search, the PL used the keywords: clinical provider, practitioner, physician, healthcare provider,
and doctor. This step in the search yielded 120 pieces of evidence. Quotations were placed
around keywords with two or more phrases and an asterisk was placed for truncation. The
limiters utilized when searching the Nursing and Allied Health database included articles that
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were peer reviewed, published in scholarly journals from 2013-2018, and were written in the
English language. It is important to note that the database only yielded evidence from 20132014.
The JBI database was searched and yielded 30 pieces of evidence. The keyword used
during the initial search included the word reminder system, which was input with quotations,
thereby yielding 16 results. Of the 16 results yielded, only one of the results was relevant to the
study. The next search included the keyword decision support system and used the Boolean
operator AND between both keywords (i.e., reminder system AND decision support system).
This search yielded 30 results. From the 30 results gathered, only 3 pieces of evidence were
relevant to the study. A third search line was included, but the PL did not consider the search as
a relevant step, specifically since this search removed relevant evidence. The keywords used in
the final step included: provider, practitioner, physician, healthcare provider, and doctor.
Boolean operators AND and OR were utilized. Furthermore, quotations were used around two
or more-word phrases. This final search yielded 22 results. Of the 22 results, only 2 pieces of
evidence were relevant to this study. The limiter used when searching the JBI database was
articles published from 2013-2018.
The PL also citation chased three pieces of evidence. Citation chasing consist of
locating a piece of evidence which was cited in another piece of evidence that was not yielded
in the search criteria but is important for a paper or project. Of the three pieces of evidence
located, two of the articles were outside of the publication date limiters. Despite the timeframe
used, the citations found were relevant and high-level pieces of evidence. Therefore, these two
citations were included to support this EBP project. The database search results for this project
are detailed in Table 2.1.
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Table 2.1
Database Search Results
Database
CINAHL

Evidence
Yielded
76

Duplicates

Reviewed

Accepted

7

20

3

Cochrane

67

0

10

3

Joanna Briggs Institute

30

0

3

1

Medline

80

5

11

1

120

1

6

0

3

0

3

3

Nursing and Allied Health
Citation chased
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Level of Evidence
The PL utilized the Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) (Dang &
Dearholt, 2018) as the selected appraisal tool. The JHNEBP tool is used to rate the level of
evidence selected. The level of evidence ratings, for each piece of evidence used in this project,
is presented in Table 2.2.
Appraisal of Relevant Evidence
An appraisal of each of the final 10 articles (Appendix A) was conducted utilizing the
JHNEBP appraisal tool. The JHNEBP rates the level of evidence and can be utilized as an
appraisal tool to analyzes the design, quality, consistency, and applicability of the evidence
(Dang & Dearbolt, 2018). The PL selected this tool because of its ease of use, detailed
description, and the rating scale utilized to assess the quality of evidence presented. The
JHNEBP rating hierarchy has five levels, levels I-III is considered researched evidence, while
levels IV-V is non-researched evidence. The rating hierarchy for the level of research evidence
is found in Table 2.2 and in Appendix A.
The JHNEBP rating tool can be used to appraised evidence. The appraisal tool allows
users to rate the quality of evidence. Quantitative and qualitative research can be appraised
using the JHNEBP appraisal tool. Quality of evidence is given a grade A, B, or C which is
consistent with a high to low rating.
Evidence given a quality grade level of high (A) has “consistent, generalizable results;
sufficient sample size for study design; adequate control definitive conclusions; consistent
recommendations based on comprehensive literature review that includes thorough reference to
scientific evidence” (Dang & Dearbolt, 2018, p. 131). For this study, there were seven quality A
graded pieces of evidence used. Studies that were given a grade A include: Arditi et al. (2017),
Fiks et al. (2013), Flodgren et al. (2016), Hendrix et al. (2015), Ivers et al. (2012), and Li (2018).
Evidence given a quality grade level of good (B) included “reasonably consistent results;
sufficient sample size for the study design; some control; fairly definitive conclusions;
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reasonably consistent recommendations based on fairly comprehensive literature review that
includes some reference to scientific evidence” (Dang & Dearbolt, 2018, p. 131). For this
project, there were three quality B graded pieces of evidence: Regan, (2017), Rokstad et al.
(2013), Shojania et al. (2009), and Zahanova et al. (2017).
Evidence given a quality grade level of low or majorly flawed (C) demonstrates “little
evidence with inconsistent results; insufficient sample size for the study design; conclusions
cannot be drawn” (Dang & Dearbolt, 2018, p. 131). For this project, there were no quality level C
grade evidence used. The quality of the evidence is discussed in the detailed level of evidence
appraisal for each piece of evidence utilized for this project. The quality rating for this research
evidence is found in Table 2.2 and Appendix A.
Level-I evidence. According to Dang and Dearbolt (2018) level-l evidence is defined as
“an experimental study randomized control trial (RCT), explanatory mixed methods with only
level I quantitative study or systematic review of RCTs, with or without meta-analysis” (p. 130).
For this project, there were four sources of evidence that were rated as level-l evidence:
Flodgren et al. (2016), Hendrix et al., (2015), Ivers et al. (2012), and Li (2018).
Flodgren et al. (2016) performed a systematic review evaluating if tools developed and
disseminated by individuals who produce guidelines are effective in ensuring guideline
implementation. For the systematic review, the authors utilized four cluster-RCTs, which were
conducted in various locations. The studies included in the systematic review of literature
focused on HCPs adherence to guideline. One of the studies used an educational workshop as
the intervention. Three of the other studies utilized forms, reminders, paper-based educational
material, or a combination of all tools to ensure compliance. The sample size included four
RCTs, which all involved HCPs, health system managers, and policymakers.
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Table 2.2
Rating Hierarchy for Level of Research Evidence using the JHNEBP Appraisal Tool
Author(s)

Grade of
Evidence

Level of
Evidence

Database

Arditi, Rege-Walther, Durieux, and
Burnand (2017)

A

II

Cochrane Database of
Systematic Reviews.

Fiks, Zhang, Localio, Khan,
Grundmeier, Karavite, … Forrest (2013)

A

I

CINAHL

Flodgren, Hall, Goulding, Eccles,
Grimshaw, Leng, and Shepperd (2016)

A

I

Cochrane Database of
Systematic Reviews

Hendrix, Downs, and Carroll (2015)

A

I

Citation chase

Ivers, Jamtvedt, Flottorp, Young,
Odgaard-Jensen, French, … Oxman
(2012)

A

I

Cochrane Database of
Systematic Reviews
Citation chased

Li (2018)

A

I

Joanna Briggs Institute

Regan (2017)

B

III

CINAHL and Medline

Rokstad, Rokstad, Holmen, Lehmann,
and Assmus (2013)

B

II

CINAHL

Shojania, Jennings, Mayhew, Ramsay,
Eccles, and Grimshaw (2009)

A

II

Cochrane Database of
Systematic Reviews
Citation chased

Zahanova, Tsouka, Palmert, and
Mahmud (2017)

B

II

CINAHL
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For each of these four reviewed RCTs, trainees and medical students were excluded.
Interventions by the World Health Organization (WHO), the National Institute for Health and
Care Excellence (NIHCE), and the Scottish Intercollegiate Guidelines Network (SIGN) were
included because these interventions involved the creation of CPGs to improve guideline
implementation (Flodgren et al., 2016). Interventions such as learning modules, educational
outreach visits, communication tools, and tailored formatting were created by CPG producers
(i.e., WHO, NIHCE, and SIGN). The creators suggested assessing the feasibility and impact of
creating templates that automatically generate patient’s data. The systematic review of literature
noted that CPG acceptance, by HCPs, may be better received and implemented when a CDSS
is utilized. The interventions were categorized according to the following classifications:
tailoring, education, targeting the patient, targeting the organization of care, and mass media
interventions. No theory guided any of the studies utilized in this systematic review. The authors
concluded that adherence to CPGs by HCPs improves when tools, developed by creators of
CPGs, are implemented. The level of evidence for this systematic review was rated a level one
and the quality was rated high, which denotes a grade A rating.
Hendrix et al. (2015) performed a (RCT) that consisted of four pediatric offices. The
researchers evaluated if highlighted prompts caused physicians to respond quicker than when
using non-highlighted prompts. Two offices were included in the intervention group which
received CDSS generated prompts highlighted in yellow. The other two offices were included in
the control group and did not receive prompts highlighted in yellow. The prompts were
randomized and were then delivered to the medical offices. The researchers also added
highlighted high-priority prompts. The high-priority prompts were not randomized because of
their importance. A total of 2237 prompts were randomized and delivered to physicians. The
results of this study did not indicate any statistically significant difference between
responsiveness to highlighted prompts versus non-highlighted prompts (odds ratio 1.056; 95%
confidence interval 0.56-1.167; p = .259, NS; X2 = 0.3; p = .58, NS). Furthermore, the
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researchers did not find improvement between physicians responding to highlighted high priority
prompts as compared to the prior years when non-highlighted prompts were utilized. Chi-square
and binary regression were utilized to analyze the RCT results. Bonferroni correction was
utilized to establish a cutoff for statistical significance. A post hoc power analysis of 80% was
obtained to detect the absolute difference in response rate of 5% for the overall study (Hendrix
et al., 2015). The researchers utilized the signal detection theory to discuss possible reasons
why physicians did not respond to highlight prompts. The researchers initially hypothesized that
highlighted prompts would result in improved responsiveness by the physicians. Intrinsic and
extrinsic factors such as lack of motivation and operational conditioning regarding responding to
reminder prompts are two possible reasons for the minimal response rates from physicians
when responding to the highlighted prompts. The researchers postulated that paper prompts
were a study limitation. The researchers suggested structured feedback about ignored prompts,
highlighting prompts on a computer screen, and hard stops in EMR systems for future
interventions to improve physician’s responsiveness to highlighted prompts. This RCT study
was given a level-l evidence rating and a quality rating grade of A by the project leader.
Ivers et al. (2012) performed a systematic review to assess the effectiveness of audit
and feedback regarding HCPs daily practice and patient outcomes. The reviewers had three
objectives that were addressed in their study (Ivers et al., 2012, p. 6):
1) Is audit and feedback effective for improving health provider performance and
healthcare outcomes?
2) What are the key factors that explain variations in the effectiveness of audit and
feedback?
3) How does the effectiveness of audit and feedback compare to other
interventions?
This systematic review included 140 RCTs that focused on audit and feedback. Audit was
defined as evaluating any individual’s professional practice, while feedback was defined as a
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process of communicating process measures to the professional. The samples included health
care professionals. Studies that focused on facilitation or reminders systems were excluded
from this systematic review. The results of this systematic review showed that healthcare
professionals who have low baseline compliance are more inclined to respond to audit and
feedback. Audit and feedback, along with other interventions (i.e., such as reminders or
educational meetings), have limitations. The acceptance of information provided in audit and
feedback depends on the individual’s mindset and motivation level. For this systematic review,
the reviews focused on individual behavioral change theories. Ivers et al. (2012) concluded that
professional practices will notice small but important improvements when audits and feedback
are used as intervention methods. When audit and feedback were the core intervention, a 4.3%
increase in compliance occurred. Compliance rates improved when using audit and feedback,
especially when these forms of feedback occurred monthly and involved individuals who have
authority, seniority, and/or were able to give a verbal or written warning. The researchers
postulate that with the proper context and design, audit and feedback will improve healthcare
professional’s practice, thereby improving patient care outcomes. The PL rated this systematic
review with a level-I score and an A quality rating.
Li (2018) performed a systematic review of RCTs studies to evaluate if implementing
audit and feedback, as a strategy, would assist in fostering HCPs practice changes. The author
evaluated four pieces of evidence. Between the four RCTs utilized, 190 studies were evaluated.
Each study contained a minimum of one piece of evidence, which focused on audit and
feedback as a strategy. Li (2018) concluded that audit and feedback alone, as well as in unison
with other strategies, can improve HCPs practice and patient outcomes. Change agents must
consider the characteristics of HCPs behaviors and the context in which these strategies are
applied. This systematic review included all RCTs; therefore, the PL rate the level of evidence a
level I. High quality, consistent, and generalizable results were provided, thereby resulting in a
grade A for this systematic review.
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Level-II evidence. Level-II evidence is defined by Dang and Dearholt (2018) as “a
quasi-experimental study, explanatory mixed methods with only level II quantitative study, or
systematic review of a combination of RCTs and quasi-experimental studies, or quasiexperimental studies only, with or without meta-analysis” (p. 130). For this EBP project, there
were four sources of level-II evidence used: Shojania et al. (2009), Arditi et al. (2017),
Zahanova et al. (2017), and Rokstad et al. (2013).
Shojania et al. (2009) performed a systematic review to assess the effectiveness of
computer reminders, during point of care visits, that are delivered on screen to HCPs. The three
objectives for this systematic review (Shojania et al., 2009, p. 3) included:
1) Do on-screen computer reminders effectively improve processes or outcomes of
care?
2) Do any readily identifiable elements of on-screen reminders influence their
effectiveness?
3) Do any readily identifiable elements of the targeted activity influence the
effectiveness of on-screen reminders?
The researchers included 28 RCTs and quasi-RCTs. Several databases were utilized by the
reviewers to obtain relevant studies related to their research topic. The inclusion criteria used for
this systematic review required that 50% of the participants were physicians or physician
trainees. The reviewers excluded studies that included nurses, dentists, pharmacists, or other
health professionals as the research’s primary focus. Adherence to computer reminders
improved by 4.2% when used as an intervention. However, computer reminders during point of
care visits, improved HCPs behavior modestly. Study interventions that targeted inpatient
settings showed an improvement of 8.7% when compared to 3% improvement in outpatient
settings (p = 0.34). Shojania et al. (2009) denoted the following systematic review limitations,
which included heterogeneity, variable degree of reporting (such as description of key
intervention features and the systems which they were delivered), and the authors median
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effects of focus. Additionally, the authors suggested focusing on quality problems or the
reminder system design as improvements for future studies/projects. No theoretical framework
guided this systematic review. The PL rated this systematic review as a level-II, using the level
of evidence scale, and gave this review an A quality rating.
Arditi et al. (2017) performed a systematic review of literature to evaluate if professional
practice and patient outcomes are affected by computer-generated reminders, which are
delivered on paper. This systematic review covered (Arditi et al., 2017, p. 7):
1) Manual paper reminders
2) Computer-generated paper reminders delivered on paper
3) On-screen reminders
The reviewers performed a thorough search of several databases to retrieve the most relevant
evidence for this review. Thirty-five studies were included in this study, which consisted of RCTs
and non-RCTs. An outpatient setting was used in all pieces of evidence, except two. The
inclusion criteria were patients, HCPs, practice, and hospitals. The review compared HCPs
normal practice, using no reminders, to computer reminders that were delivered on paper. Using
computer reminders, delivered on paper, as a multifactorial intervention and/or alone, slightly
improved care by 6.8%. In a single intervention, computer-generated reminders, which were
delivered on paper to HCPs, improved quality of care by 11%. Adding reminders as an
intervention to another intervention improved the quality of care by 4.0%. The reviewers
concluded that computer-generated reminders, which are delivered on paper, slightly improves
the quality of care received with moderate-certainty. Arditi et al. (2017) noted the following
limitations for the systematic review: (a) evidence certainty because of low level of evidence and
quality ranking, (b)methodology, (c) inconsistency, and (d) wide confidence intervals of the
utilized studies. The authors provided the following recommendations for future studies: (a)
reminders be used in a variety of settings, (b) leave space on the reminder for responses for the
HCPs, (c) explanation of the content of the reminder, and (d) provide relevant sources with large
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effect sizes. Arditi et al. (2017) concluded with moderate certainty that the quality of care of
patients moderately improved when HCPs received computer generated reminders delivered on
paper regarding CPG compliance. No theoretical framework guided this systematic review. The
PL rated this systematic review as a level-II, using the level of evidence scale, and gave this
review an A quality rating.
Zahanova et al. (2017) performed a pilot study utilizing the iSCREEN Diabetes
Dashboard at a pediatric diabetic clinic during point of care visits. The researchers hypothesized
that CPG adherence by HCPs, knowledge of CPGs, and easy access to guidelines and patient
information would improve through utilizing the CDSS. iSCREEN was implemented to assist in
preventing overscreening, as well as to remind HCPs when testing was needed, as based on
the Canadian Diabetes Association (2013) CPGs for the Prevention and Management of
Diabetes. This study included 50 adolescents, who were between the ages of 14 to 18, and had
a diagnosis of type 1 diabetes. Twenty-five charts were reviewed during the pre-intervention
phase and 25 charts were reviewed during the post-intervention phase. To obtain baseline
knowledge of pre-intervention practice behaviors, five charts from five different endocrinologist
were reviewed. The researchers used a convenience sample and the first five eligible patients,
of that year, were selected to have their charts reviewed. The researchers stated they took all
precautions to eliminate bias, though they noted that bias may exist. Patients were excluded
from the study if they were enrolled in another study, had celiac disease screenings that needed
to be performed, or were adolescents who were diagnosed with T2DM. The researchers
screened subjects for microalbuminuria, retinopathy, thyroid disease, dyslipidemia, and HTN
using three different categories (i.e., adequate, inadequate, or over screened). HCPs were
given a pre-test and post-test survey, which consisted of 10 multiple choice questions and three
Likert scale type questions, that was used to assess HCPs knowledge of CPGs, as well as
access to CPGs. Zahanova et al. (2017) addressed the following in their study:


frequency of adequate screening of complication and comorbid conditions,
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scores on knowledge questionnaires, and



relative ease of access to guidelines and patient information with the launch of
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iSCREEN dashboard.
Upon the implementation of the intervention (i.e., post-intervention), underscreening and
overscreening decreased (p = 0.03) for nephropathy screening. Furthermore, the amount of
initial nephropathy screening improved. Initial retinopathy screening also improved (p = 0.04).
Dyslipidemia and thyroid function screening showed no statistically significant change.
Hypertension screening had no statistically significant change from 90% at baseline. Preintervention (n = 31) and post-intervention (n = 27) surveys were collected. Following the
successful launch of the CDSS iSCREEN, an 11% improvement of knowledge of CPGs was
noted. This pilot study supported Zahanova et al.’s (2017) hypotheses that knowledge of CPGs,
easy access to guidelines, and knowledge of patient information, in CDSS, can improve
adherence to CPGs among HCPs. Zahanova et al. (2017) provides the following limitations: (a)
retrospective study, (b) small and feasible sample size, (c) the control group was historical, (d)
invalid knowledge questionnaires, and (e) the inability to perform a power analysis prior to
beginning the study. The researchers suggested the iSCREEN tool be used in PCP offices and
diabetic education clinics. Zahanova et al. (2017) further suggested future studies should be
conducted long term to evaluate if knowledge translation retention improved, and to evaluate
patient outcomes and iSCREENs cost to healthcare. The researchers concluded that guideline
compliance can have an impact on healthcare cost and patient outcomes when incorporated in
the iSCREEN tool. There was no discussion of IRB approval nor was there a theoretical
framework used to guide this study. The PL rated this systematic review as a level-II, using the
level of evidence scale, and gave this review a B quality rating.
Rokstad et al. (2013) conducted a pilot study to improve patient referrals to specialist by
general practitioners (GPs). This study was conducted at outpatient clinics of Haukeland
University Hospital, which receives approximately 2400 annual patient referrals. For this study,
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an electronic optional guideline tool was used in 93 GP offices to assist in the referral process
for patients who presented with sleep apnea, chronic obstructive pulmonary disease, and lung
tumors. EMR systems were updated at 93 GP offices to include the electronic optional guideline
tool. The control group consisted of 117 GPs whose EMR systems were not being updated;
therefore, normal practice for referral to specialist continued. The researchers compared the
intervention group to the control group. Both groups were evaluated without their knowledge.
Referral consideration and management was timed. The anonymous evaluation form was
scored on a 0-10 scale, based upon referral diagnoses. The researchers conducted telephone
interviews with GPs who were part of the intervention group. Information obtained during
telephone interviews included details about system usage, ease of use, the time used to write
referrals, and feelings about referral improvement. Rokstad et al. (2013) analyzed the variables
referral time and total score collected on the anonymous evaluation forms using a betweengroup design. During this study, there were 1080 new referrals for patients who presented with
sleep apnea, chronic obstructive pulmonary disease, and lung tumors. The researchers stated
that 664 referrals were from GPs; however, it was unknown if the GPs were from the
intervention group or the control group. One can assume that GPs were from the intervention
group. Anonymous evaluation form analyses noted a 30% rate of referral improvement from
GPs to specialist in all diagnostic groups. There were no significant differences in referring
patients for a chest x-ray (p = 0.142) and CT thorax (p = 0.234) when the suspected diagnosis
was a lung tumor. The researchers also assessed for burnout among members of the
intervention group and found no significant difference between groups. Those who were in the
intervention group spent 34% less time on referrals, as compared to those in the control group.
The intervention group began with 93 GPs; however, only 82 GPs reported that they had utilized
the new electronic optional guideline tool. Of the 82 GPs who utilized the tool, 96% stated the
tool was useful, saved time, and was easy to utilize. Rokstad et al. (2013) noted the following
limitations to this study: (a) non-randomization of the Bergen GPs which created bias, (b)

37

PREVENTING PRIMARY CVD: CPG COMPLIANCE

38

inability to differentiate whether the GP was a specialist, and (c) some of the referrals included
were not from the GPs in the study. The researchers did not provide suggestions for future
studies but, they addressed how this study addressed suggestions from past studies. The
researchers concluded that implementation of the electronic optional guideline tool should be
used in a variety of setting because it saves time, will assist with efficiency and quality of care in
outpatient clinics regarding referrals. The researchers did not use a theoretical framework to
guide this study. The PL rated this systematic review as a level-II, using the level of evidence
scale, and gave this review a B quality rating.
Level-III evidence. A quantitative nonexperimental study; explanatory mixed methods
with only level III quantitative study; exploratory, convergent, or multiphasic mixed methods
studies; systematic review of a combination of RCTs, quasi-experimental, and nonexperimental
studies, or nonexperimental studies only; or qualitative study or systematic review of qualitative
studies, with or without a meta-synthesis (Dang & Dearholt, 2018, p. 130).
There were two sources of level III evidence (Fiks et al., 2015; Regan, 2017) used for this EBP
project.
Fiks et al. (2015) hypothesized that an increase of clinical decision support (CDS)
system implementation would result in an increase of feedback on performance. The
researchers had three aims for this study (Fiks et al., 2015, p. 492):
1) characterize patterns of adoption of the CDS,
2) assess the impact of performance feedback on CDS adoption by primary care
clinicians, and
3) measure the impact of CDS use on guideline adherence.
Clinical decision support systems were to be received by 16 practices, which were randomized
by the researchers. A second randomization of practices was completed. This randomization
was determined by the practice level to physician performance feedback. However, some
practices were not randomized. HCPs who regularly treat patients who have otitis media, acute
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otitis media, otitis media with effusion diagnosis, and children ages 2 months through 12 years
were included in this study. HCPs who had 25 or fewer patients who have otitis media were
excluded from this study. This study is an extension of a previous study conducted by Forrest et
al. in 2013. Interventions of this study included study explanation, education about otitis media
CPGs, and the use of CDS. Feedback regarding baseline data was given after 1 year of CDS
implementation. During the next 10 months, the researcher’s hand-delivered six rounds of
feedback to the randomized sites. The control group did not receive feedback or any further
interaction; however, they had access to CDS. To measure adherence to acute otitis media
guidelines, four measures were utilized, which includes: “(a) appropriate use of amoxicillin as a
first-line antibiotic, (b) use of high-dose amoxicillin, (c) pain assessment, and (d) analgesia use”
(Fiks et al., 2015, p. 496).
Fiks et al. (2015) noted that CDS otitis media tool adoption rates were low. In fact, the
tool was never utilized by two clinicians. Furthermore, 12 of the clinicians did not use the CDS
tool after the 3-month trial period. The CDS was utilized in less than 10% of the visits by 38.9%
of the HCPs. At 10-25% of the visits the CDS tool was used by 20.3% of the clinicians. Further,
30% of clinicians used the CDS tool during 21.3% of visits. The CDS tool was utilized an
average 16.8% based on practice level. Practices that saw fewer otitis media patients were
more inclined to utilize the CDS tool. The CDS tool was more heavily utilized during sick visits
as opposed to well visits. The CDS tool was utilized in children 2-5 years old but less in children
less than 6-months (p = .05), and children at high risk for adverse outcomes (p = .02).
Feedback increased a practice’s usage of CDS, especially among practices that
received the multifactorial intervention as compared to practices that received the single CDS
intervention tool (Fiks et al., 2015). Practices had a 2.2%-point increase in CDS tool usage with
feedback compared to 6.8% decrease in non-feedback practices when compared to baseline
data. The CDS tool usage with feedback increase was statistically significant (p = .001) with a
relative difference of 9.0% points regarding the 10-month and 12-month comparison.
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Otitis media CPG adherence in association with CDS usage improved adherence among
HCPs regarding CPGs. There was a relative increase of 7.5 (p < .001) and 8.6 (p = .01) in CDS
usage in acute otitis media care with and without effusion. Pain treatment had a 48.2%-point
relative increase for all types of otitis media. Amoxicillin, prescribed as first-line therapy, had a
5.4%-point relative increase. Furthermore, there was a 4.9% relative point increase among
patients who had a penicillin allergy who were prescribed the appropriate antibiotic. High-dose
amoxicillin prescription rates had a 17%-point relative increase (Fiks et al., 2015). Unfortunately,
the researchers noted that a 2.7% relative increase in non-indicated antibiotic prescriptions
occurred. A CPG improvement rate of 12% was noticed in otitis media with effusion diagnosis.
Rogers’ theory of diffusion of innovation (1970, 1986, 1990) was utilized as a theoretical
framework to guide the study by Fiks et al. (2015). The implementation of the CDS for this
project is innovative to its users. Fiks et al. (2015) projected that physicians will fully convert to
utilizing the CDS instead of the using the normal process of decision making. The interventions
were not complicated, testing did not take a significant amount of time, and the benefits were
noticed by users. Feedback was an intervention to assist participants to recognize the benefits
of the CDS. The context from conversations held during feedback visits evaluated the use of
CDS for otitis media. Some HCPs felt EHR benefitted their practice, while others felt that EHR
involved too many button clicks and was too burdensome to use for patients who expressed
multiple complaints. Some HCPs also preferred typing notes themselves due to the complex
nature of the CDS tool. Overall, the results of this study demonstrated that HCPs who had low
guideline compliance benefitted the most from the CDS tool. The researchers noted limitations
for this prospective cohort study included: (a) the study was evaluated based on the description
of CDS tool adoption, (b) instead of randomization, and (c) it was conducted in one healthcare
system. Suggestions made by the researchers for future improvements are to evaluate the
independent effect of CDS adoption on patients’ diagnosis and chief compliant. The PL rated
this study as having level-III evidence and provided an A grade for quality of the evidence.
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Regan’s (2017) study aimed to improve the knowledge of HCPs regarding chronic
kidney disease, as well as to improve awareness of CPGs to increase early point of care
referrals to nephrologists. The study was conducted in an organization composed of 80 HCPs,
who worked in 11 primary care offices. No nephrology group was affiliated with the organization
where this study occurred. The JBNEBP model guided this study, since the model focuses on
EBP implementation in the clinical setting. In the study’s setting, there were 60,985 active
patients (pre-implementation). After intervention implementation, 64,577 patients were seen.
The study used an anonymous optional survey to assess HPCs knowledge about chronic
kidney disease. Upon the completion of the anonymous optional survey, during a stakeholders’
meeting, details regarding vital baseline patient data, an educational presentation about chronic
kidney disease and tutorials about the CDS pathway was provided to stakeholders. Since not
every HCP was able to attend this stakeholders’ meeting, educational materials were sent to
every HCP. Reminders regarding the chronic kidney disease project and measures was sent
during the first month of implementation. The CDS intervention was evaluated for progress and
improvement areas. Feedback about the projects progress and improvement was sent via email
to HCPs. Three months after implementation of the CDS intervention, data collection began.
The researchers performed a post-intervention survey to assess HCPs knowledge. Participation
in this survey was optional. Patients who were 18 years and older and arrived at their schedule
appointments were included in this study. Patients were excluded if they were inactive patients
or passed away during the time of the study. During this study, the following variables were
evaluated: diagnosis of chronic kidney disease, stage 3-5 chronic kidney diagnosis, diabetes
and chronic kidney disease, HTN and chronic kidney disease, estimated glomerular filtration
rate < 60 ml/min and < 30ml/in with or without diagnosis of chronic kidney disease, chronic
kidney disease or estimated glomerular filtration rate < 60 ml/min with albumin/creatinine ratio
results, chronic kidney disease linked nephrology referrals, and patients with estimated
glomerular filtration rate < 30 ml/min or albumin/creatinine ratio (ACR) > 300 mg/g with a
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nephrology referral. Forty-four of the 80 HCPs completed the optional survey at baseline and 23
HCPs completed the post-intervention survey. Laboratory testing specific for chronic kidney
disease (Z = -2.00, p = .046), chronic kidney disease stages interpretation (Z = -2.83, p = .005).
Patient who presented with a diagnosis of chronic kidney disease, overall assessment improved
significantly (Z = - 2.41, p = .024). Overall knowledge regarding chronic kidney disease greatly
improved (U= 335.50, p = .01). Patients who were referred to a nephrologist as well as patients
who were recently diagnosed with chronic kidney disease, regardless of the variable evaluated
(e,g, glomerular filtration rates less than 60 ml/min or urine microalbumin test with an
albumin/creatinine ratio results), significantly improved. The findings of this study were
consistent with previous research studies that support PCPs using CDS at point of care visits to
for chronic kidney disease guideline dissemination and algorithm management (Regan, 2017).
Regan (2017) provided several limitations in this study: (a) generalizability, (b) homogeneity, (c)
composition of the organization, (d) a small number of HCPs responded to the survey, (e)
knowledge deficits of existing survey because it was sent to their work email, (f) only physicians
received the CDS tool education etc.). The researcher suggested HCPs in primary care
increase their knowledge base and awareness about chronic kidney disease and incorporate
ways to promote guidelines using a CDS tool. For detection of early stages of chronic kidney
disease, a large-scale research study with risk stratification is suggested. Regan (2017)
concluded that chronic kidney disease guidelines be followed through a CDS tool by HCPs.
CDS tools assist PCPs with detection and management of chronic kidney disease, assist with
healthcare cost, and improves the care and safety of patients. The PL rated this systematic
review as a level-III, using the level of evidence scale, and gave this review a B quality rating.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
This literature review provided information about numerous strategies that HCPs can
utilize to follow recommended evidence-based CPGs. Breaking down barriers held by HCPs
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about implementing CPGs can be done by using various educational strategies (i.e. face-to-face
presentation, computerized education, etc.), tailoring CPGs to ensure user friendliness,
developing different versions of CPGs (i.e. for organizations and another public or media use),
and promoting strategies to inform HCPs that new CPGs recommendations are available
(Flodgren et al., 2016) are critical to ensure CPGs are implemented for improved patient
outcome. When CPGs are not followed, patient outcomes are less than optimal. Therefore, it is
imperative for HCPs to select the best strategy to implement CPGs in their daily practice,
thereby ensuring that CPG utilization is easily supported, efficient, and effective.
Although several studies focused on a single approach to CPG adherence (Arditi et al.,
2017; Pantoja et al., 2014; Regan, 2017; Rokstad et al., 2013; Shojania et al., 2009; Zahanova
et al., 2017), other studies supported the use of a multi-modal approach (Fiks et al., 2015;
Flodgren et al. 2016; Hendrix et al., 2015; Ivers et al., 2012; Li, 2018). Education is an important
intervention for HCPs to learn about CPGs. Education alone is not an effective strategy for
improving CPG adherence among HCPs. Historically, paper alerts were used as a strategy to
prompt HCPs about patient needs; however, with the usage of computer/electronic systems,
paper prompts are not being utilized as often as they once were. Unfortunately, issues arise
with computer/electronic alerts. For example, HCPs are inundated with numerous
computer/electronic alerts, which cause alert fatigue, thereby resulting in ignored or overlooked
alerts (Hendrix et al., 2015; Shojania et al., 2009; Zahanova et al., 2017). Regardless,
researchers have noted that CDSS, computer-generated alerts, or EMR systems have been
beneficial and effective in ensuring HCPs adherence (Fiks et al., 2015; Hendrix et al., 2015;
Shojania et al., 2009; Zahanova et al., 2017). Visual cues in the form of flowsheet (Appendix B)
are an easy and concise intervention that will assist HCPs follow CPG recommendations.
Flowsheets helps reading and understanding CPGs less time consuming. Audit and feedback
can improve adherence among HCPs, specifically about following CPG recommendations.
Providing feedback to HCPs makes them aware that improvement is necessary regarding
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following CPGs. No matter what strategy HCPs implement, it is critical that they use this
strategy/resource on a continuous basis, thereby resulting in improved patient outcomes.
Best Practice Model Recommendation
Evidence shows that the best way to facilitate CPG compliance among HCPs is for
computer prompts as reminders be placed in the EMR system. Shojania et al. (2009) suggested
CPG compliance is best with computer prompts, but better compliance is noted with computer
prompts at point of care visits. Zahanova et al. (2017) suggested CDSS improves CPG
compliance because it provides HCPs with easy access to CPGs, knowledge about CPGs and
access to patient information. Rokstad et al. (2013) stated that although HCP were given an
option of using the electronic optional guideline tool that it was bypassed by some HCPs.
Rokstad et al. (2013) stated that HCPs who utilized the electronic optional guideline tool found it
was advantageous when treating patients. Fiks et al. (2015) found mixed reviews about CDS
tools from HCP. Some HCPs found the CDS tool feasible for their practice while other
suggested the CDS tool was too time consuming (Fiks et al., 2015). Arditi et al. (2017)
suggested computer-generated reminders be delivered on paper with or without another
intervention improved CPG compliance. Hendrix et al. (2015) noted EMR system reminder
fatigue; therefore, HCPs bypassed and disregarded the reminder prompts in the EMR system.
Hendrix et al. (2015) suggested using hard stops as an intervention to prevent HCPs from
bypassing CPG recommendations in the EMR system.
How the Best Practice Model Will Answer the Clinical Question
The best practice model will be used to answer the clinical question, “For healthcare
providers in a primary care setting, does incorporating a multi-modal approach that involves
education, using computer-generated paper reminders at point of care, visual cues, and
ongoing feedback about prescribing performance improve the initiation of medication therapy for
the prevention of primary CVD in at-risk adult patients in a 7-week period?” Incorporating all
elements and sub-elements of the PARiHS framework and giving equal value to each element
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allowed for successful EBP implementation to occur. The major elements of evidence, context,
and facilitations were essential to implementing CPGs into practice (Kitson et al., 1998).
Computer-generated 10-year ASCVD calculated risk factor calculations were delivered
to HCPs on paper. These scores served as a reminder to initiate a statin and/or aspirin for
patients at-risk for primary CVD. The PL conducted an educational intervention about the
benefits of using evidence-based practice CPGs to prevent primary CVD. Thus, this educational
intervention will keep HCPs abreast of the need to initiate a statin and/or aspirin in patients’ atrisk for primary CVD. The context where this EBP project was conducted was a very busy, fast
paced practice. Given the nature of pace in this practice, medical assistants were responsible
for performing the 10-year ASCVD risk factor calculation, which was given to HCPs, which did
not drastically change the workflow for HCPs. Teamwork, communication, and knowledge
regarding how to perform the PCE, for appropriate patients, resulted in smoother project
implementation during the first week. Focusing on all elements and sub-elements of the
PARiHS framework helped the project leader answer the clinical question guiding this evidencebased practice project.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
Evidence-based practice can greatly assist in changing practice behaviors. Groomed to
be leaders and change agents, DNP prepared nurses can make long-term/long-lasting
healthcare practice changes. “Practicing in the clinical setting provides an environment for the
DNP graduate clinician to develop and utilize skills pertaining to evaluating, integrating, and
implementing EBP” (Chism, 2016, p. 76). Doctor of nursing prepared nurses are often able to
make contributions through the application of knowledge and scholarship (Boyer, 1990; Chism,
2016), thus providing institutions with the best evidence available to improve the future of
nursing care.
This EBP project took place in a Midwestern urban community-based clinical setting. The PL
evaluated whether patients 40-75 years of age, who are at-risk for primary CVD, were receiving
statins or aspirin (which is recommended by the ACC/AHA, AHA/ADA CPGs, and USPSTF).
During this project, a multi-modal approach that included four strategies was implemented:
1. Education was used to provide the latest CPGs to prevent primary CVD. Computergenerated reminders, on paper, were introduced at point of care visits to alert HCPs
about patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM.
2. The Pooled Cohort equation was utilized to calculate at-risk patients 10-year estimated
ASCVD risk factor. Once the ASCVD computer-generated calculation was obtained, the
office staff printed out the calculation, wrote the patient’s medical record number in the
upper right-hand corner then made it accessible to HCPs during point of care visits. An
estimated ASCVD 10-year risk factor greater than or equal to 7.5 mg/dl on the PCE and
an at-risk diagnosis alerted HCPs to prescribe a statin and/or aspirin, which is based on
CPGs.
3. For the visual cues, copies of the CPG flowchart (Appendix B) were placed in each
examination room as a quick reminder.
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4. Patient charts of all three participants were audited and feedback was provided to HCPs
on a weekly basis via letter format.
Participants and Setting
This project took place in a low-income urban walk-in clinic located in the Midwestern
region of the United States. In this walk-in clinic, there are a total of six staff members. The staff
members consist of three HCPs (one physician and two nurse practitioners), two medical
assistants, and one office manager. Participants included in this evidence-based project
consisted of a physician and two family nurse practitioners who have prescriptive authority.
Participants excluded from this study are those who worked in the primary care office but, did
not have prescriptive authority. Although the medical assistants were not participants in this
EBP project, they played a vital role by collecting data from patient charts, inputting the data into
the PCE at point of care visits, printing off the computer-generated PCE then placing it in the
examination room on the computer for the HCP to obtain.
The physician had stated to others that he is comfortable with his daily practice and is
not interested in following CPGs. The newest FNP has less than 3 years of experience and
works closely with the physician. The other FNP has over 10 years of clinical experience but
stated, “there is no time to read through CPGs.”
In 2018, it was projected that approximately 500 patients were seen per month (T.J.
Harvey, personal communication, July 5, 2018). Many of the patients seen at the clinic have
several comorbidities, which include dyslipidemia, HTN, T2DM, and obesity. Additionally, many
are smokers. T. J. Harvey (personal communication, April 24, 2018) stated, “this is a great
project and is necessary in this office.”
Outcomes
The targeted outcome was to improve compliance among HCPs with prescribing statins
and/or aspirin for the primary prevention of CVD among at-risk adult patients. This
recommendation was based upon the standards set forth by Fox et al., 2015; Stone et al., 2013;
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Whelton et al., 2016; USPSTF (2016) in the CPGs. The PCE was utilized to calculate the 10year ASCVD risk factor for patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM,
which assesses an individual’s risk for a cardiovascular event. Adherence was determined by
using chart audits, which were conducted before, during, and following the intervention.
Intervention
The interventions used in this project included a multi-modal approach, which
encompassed four strategies: (a) education, (b) computer-generated reminders on paper, (c)
visual cues, and (d) audit and feedback to assist in improving HCP compliance (i.e., prescribing
statins and/or aspirin for the primary prevention of CVD. Education about the ACC/AHA (Stone
et al., 2013, 2018), AHA/ADA (Fox et al., 2015) CPGs and the USPSTF (2016) to prevent
primary cardiovascular disease among at-risk patients who had an ASCVD of greater than or
equal to 7.5% was provided to HCPs, the medical assistants, and office manager. Education
was also provided regarding how to utilize and where to locate the PCE on the AHA and ACC
website. Demonstration by the PL and redemonstrations of completing the PCE was performed
as part of the educational phase. This education was provided to the medical assistants and the
office manager; however, the office manager stated, she would not be able complete any
ASCVD risk factors because of her workload (S. Sams, personal communication, October 5,
2018).
Although evidence showed that best practice involves reminders embedded in the EMR,
the affiliated hospital did not want to change the EMR system because organizational leaders
believed a change in the EMR would interrupt HCPs workflow throughout the system.
Therefore, computer-generated paper reminders were selected as the intervention. During
point-of-care visits, the medical assistants collected patient data from their charts regarding
ethnicity, gender, age, current blood pressure, LDL-C, high density lipoprotein (HDL), total
cholesterol, history of T2DM, current, former or never a smoker and whether the patient is on a
statin, aspirin, and/or blood pressure medication input this information into the PCE to calculate
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the 10-year estimated ASCVD risk factors of at-risk patients. Once the estimated 10-year
ASCVD risk factor calculations were generated from the computer utilizing the PCE from the
AHA or ACC website, the medical assistant printed the results. To ensure that calculations was
made quickly, the PCE remained open on computers. The medical assistant who performed the
PCE wrote the patient’s medical record number, as the patient identifier, in the upper right-hand
corner of the paper. The printed calculation informed the HCPs that a patient's ASCVD risk is
greater than or equal to 7.5 mg/dl.
When at-risk patients were taken to the examination room by the medical assistant, the
printed computer-generated calculation was placed on the computer in the patients’ examination
room; however, at times it was placed in the box outside of the patients’ examination room for
the HCP to access and review. By providing the computer-generated PCE calculations, the
paper reminder was readily available to HCPs, when they provided care, thereby increasing the
likelihood that preventative medication was initiated.
To ensure visibility of the CPG, the PL placed copies the CPG flowsheet (Appendix B) in
each examination room. The flowcharts served as a quick reminder of the CPGs. The
flowsheets provided information to HCPs regarding how to follow the recommended CPGs for
at-risk patients with an ASCVD greater than or equal to 7.5%.
To provide feedback, the project leader performed weekly chart audits. Weekly chart
audits included randomly selecting five patients from each of the HCPs and evaluating
compliance rates among HCPs. Aggregated data regarding compliance or issues with initiating
a statin and/or aspirin were presented to the HCPs with a weekly feedback letter because the
HCPs were never in the office together. Monthly lunches were provided to the staff as a
celebration of short-term goals. During the monthly lunches, verbal feedback was provided
about the progression of the project. Since all HCPs are not in the office on the same day, the
PL went to the office on physician days to buy the physician lunch, but lunch was refused
because of the number of patients.
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Planning
The PL discussed the idea of conducting a project about prescribing statins to T2DM
patients to the project liaison in April of 2018. The PL noticed several patients who came into
the office with T2DM and were not prescribed a statin or an aspirin. The project liaison stated
that the EBP practice topic was necessary in this clinical setting. While completing a pilot chart
audit in August 2018 to evaluate if conducting an EBP project about prescribing T2DM patients
a statin and/or aspirin, it was noted that patients who were diagnosed with dyslipidemia and
HTN also did not have a statin or aspirin prescribed as recommended by the evidence-based
CPGs. Evaluating the pilot data, the PL noticed that more patients with T2DM were prescribed a
statin. Communication occurred between the PL and the liaison about T2DM and statins. The
project liaison informed the PL that insurance companies were now sending correspondences to
the office as a reminder to HCPs to prescribe a statin to all T2DM patients. The PL and the
project liaison then discussed completing the EBP project about prescribing statins and/or
aspirin to patients who were diagnosed with dyslipidemia, HTN, and T2DM.
The PL then communicated with the physician in the office about conducting this EBP
project in the office; however, all details were not revealed because the PL did not want to
introduce bias or the Hawthorne effect. The PL found after several literature searches about the
best evidence for HCP to comply to CPGs was prompts in the EMR system. After the approval
was given by the physician, the PL communicated face-to-face and email correspondences with
several individuals at the affiliated hospital about incorporating an EMR alert system into the
current electronic database for the medical assistants to complete for each at-risk patient’s
during triage. Later, the PL was informed by individuals at the affiliated hospital that changes to
the EMR was unable to be made for this EBP project because it would disrupt HCP flow in the
office and the changes could not be made for one office.
After rejection of computer prompts in the EMR system by the affiliated hospital, the PL
searched the literature to find the next best option for HCP to adhere to CPGs. The next best
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option found in the literature was computer-generated alerts printed on paper as reminders for
HCP to adhere to CPGs. Interventions about audit and feedback were also discovered in
several research articles during the literature search. The PL decided to perform weekly chart
audits about the HCPs compliance with prescribing a statin and/or an aspirin to at-risk patients
based on the research articles read. The PL discussed with the medical assistants and the
office manager that an EBP project was going to be performed at this urban walk-in clinic. The
PL informed the medical assistants and office manager that their help was going to be needed
to complete this project. All parties agreed to assisting with the EBP project. After deciding
which appraisal tool, change theory, and EBP model to guide this EBP project, the PL sent
email correspondences to Johns Hopkins and John Kotter for permission to utilize their
information for this EBP project. Permission was not needed from the ACC and AHA to use their
information for this EBP project.
The PL created a PowerPoint presentation to educate the HCPs, medical assistants,
and office manager about the urgent need of the EBP project in this clinic. The PL taught the
medical assistants and the office manager how to obtain the PCE to calculate the 10-year
ASCVD risk factor using the website. The PL explained that their roles in this EBP project was
the gatekeepers.
Data
Data were collected before, during, and after the intervention. Chart audits included
patient data to evaluate HCPs adherence to prescribe a statin and/or aspirin if patients had a
diagnosis of dyslipidemia, HTN, and/or T2DM and were ages of 40-75 and never had a
cardiovascular event which included stroke or open-heart surgery. The patient’s medical record
number was utilized as a patient identifier; however, only the PL and academic advisor had
access to this. It is important to note that age and gender information were necessary in the
PCE to obtain patients 10-year ASCVD risk factor. All data were placed in an Excel spreadsheet
then transferred to SPSS version 22.
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To be compliant with confidentiality rules and Healthcare Insurance Portability and
Accountability Act (HIPPA), after point of care visits paper reminders were placed in a manila
folder by the office managers desk or in the physicians’ outbox. Computer-generated paper
reminders placed in the physician outbox were then retrieved by the PL or the medical
assistants then placed in a manila folder, which was kept at the front desk. The PL collected the
computer-generated reminders which displayed patients 10-year ASCVD risk factor on a weekly
basis. The computer-generated reminders are locked in a file drawer in the PL’s home. Data
typed in the Excel spreadsheet on the PL’s computer were and continue to be password
protected and saved on a universal serial bus (USB) flash drive which was and continues to be
kept in a locked file drawer. At the end of the project, the computer-generated paper reminders
and chart audit data will continue to be kept in a locked filed drawer in the PL’s home until the
time limit has been reached for it to be destroyed. The PL and EBP project advisor are the only
people who had access to the data.
Measures and their Reliability and Validity
The PCE was used to measure a patient’s ASCVD 10-year estimated risk factor which
tells patients risk for primary CVD. The PCE can be located on the AHA or ACC website:
http://static.heart.org/riskcalc/app/index.html#!/baseline-risk or http://tools.acc.org/ascvd-riskestimator-plus/#!/calculate/estimate/. The PCE is a reliable and valid tool to obtain patients 10year estimated ASCVD risk factor as evidenced by a c-index of 0.82 in women (95% CI: 0.780.86) and 0.74 (0.71-0.78) in men. Although validity was provided for the PCE, recalibration
improved the equations performance using the Hosmer-Lemeshow Chi-square, which resulted
in scores of 23.8 in women and 56.7 in men (Khalili et al., 2015). Emdin et al. (2016) and Khalili
et al. (2015) postulated that although the PCE is valid but it still has flaws. The equation
overestimates a patient’s risk of CVD by 57% in women, 48% in men (Khalili et al., 2015) and
167% overall (Emdin et al., 2016). However, the ACC/AHA (Stone et al., 2013) CPG
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recommends the use of the PCE, as it has been successfully used in many national and
international studies over time (Fox et al., 2015; Garza et al., 2017; Stone et al., 2013).
Data Collection
When the PL piloted this study, 100 patient charts were audited to assess the project’s
feasibility. The PL recognized that out of the 100 charts audited, 18 patients met the criteria of
having T2DM and a 10-year ASCVD risk factor of greater than or equal to 7.5% for the initially
planned EBP project. It was presumed that there was low number of T2DM patients identified,
who met the criteria during chart audits, because insurance companies began sending
reminders into the office for HCPs to initiate statins for diabetic patients (T.J. Harvey, personal
communication, July 24, 2018). Recognizing the low number of T2DM patients, who met this
EBP project’s criteria, the project leader decided to collect additional data. Patients who were
diagnosed with dyslipidemia, HTN, and/or T2DM and were not prescribed a statin and/or aspirin
were included in the study. Ultimately, the PL shifted the focus of this EBP project to include all
patients who are at-risk (i.e., who present with dyslipidemia, HTN, and/or T2DM diagnosis) for
primary CVD.
The PL performed the pre-intervention chart audits during the Fall of 2018 semester,
after IRB approval was granted. The PL randomly selected 100 patient charts for audit during
the pre-intervention phase of this EBP project. During the audit process, the PL evaluated HCPs
adherence to prescribing a statin and/or aspirin in patients ages 40-75 years old who presented
with a diagnosis of dyslipidemia, HTN, and/or T2DM. During the implementation phase of the
intervention, chart audits occurred weekly. The PL randomly selected five patient charts of each
of the HCPs in the office. Aggregated data were provided to HCPs to provide feedback about
adherence to the EBP project. During post-intervention, the PL randomly selected 100 patient
charts to audit to evaluate if the HCPs are continuing to follow the CPGs by prescribing a statin
and/or aspirin in patients at-risk for the prevention of primary CVD.
Sample
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The sample for this EBP project included three participants. The participants included
one physician and two FNPs who had prescriptive authority. Although, the HCP were the focus
of this EBP project patient charts were audited to evaluate HCP compliance with prescribing a
statin and/or aspirin to at-risk patients. Patient charts audit included patients who were 40-75
years of age and had been diagnosed with dyslipidemia, HTN, and T2DM. For the project, 300
charts were audited. However, not all patients met the inclusion criteria. For example, audits
showed that some patients had an ASCVD of less than 7.5 were not prescribed statins or
aspirin, which although compliant with the CPGs, was not the focus of the PICOT question.
After removing patients who did not meet the inclusion criteria, 243 patient charts were included
in the final sample.
Management and Analysis
Data, obtained through chart audits, was initially entered in an Excel spreadsheet then
transferred to SPSS software (Version 22). Descriptive statistics were calculated to describe the
frequency of the patient chart sample characteristics. These characteristics are detailed in Table
4.1. The PL utilized a cross tabulation Chi-square test to analyze the compliance rates of HCP
with prescribing statins and/or aspirin to patient with the risk factors of an ASCVD greater than
or equal to 7.5%, dyslipidemia, HTN and T2DM (See Table 4.2 and see Figure 4.1 for details).
Secondary outcomes about HCP prescription preference and how many patients received a
statin only, aspirin only, both, or none based on risk factors are discussed in Chapter 5.
Frequencies were calculated to assess the number of comorbidities that were plaguing the
HCPs and patients at this walk-in clinic. Details about these incidental findings are discussed in
Chapter 5.
Protection of Human Subjects
Expedited IRB approval was obtained through the Methodist Hospitals, Inc. and
Valparaiso University. The PL created a proposal summary and completed the IRB for project
approval by Valparaiso University. The PL was initially informed by an individual at the affiliated
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hospital that IRB was not needed because the EBP project was not research. The PL continued
to question the need for IRB at the affiliated hospital until the PL found out that IRB approval
was necessary. The PL then completed the IRB approval for the affiliate hospital. The initial IRB
for Valparaiso University and the affiliated hospital was returned for revising. The IRBs for both
entities was revised and sent back. In approximately the middle to end of September the IRB for
both entities was approved.
The PL created a consent form (Appendix C) for the three participants (the one
physician and two HCPs) to sign for participation in this EBP project. This EBP project began
the first week in October 2018, in which the PL was in the office the entire week to answer
questions and assure project initiation was a smooth transition. The PL implemented this project
in the Fall of 2018 and completed in March of 2019 (see Table 3.1 and 3.2 for the Actual
Timeline).
On a weekly basis, the PL collected the paper reminders, which were placed in a manila
folder located at the front desk. These paper reminders were put into the manila folder after
point of care visits by the medical assistants or they removed them from the physician’s outbox.
To protect participants, the PCE with patients 10-year ASCVD risk factor was locked in a file
drawer, which is located in the PLs’ home. Data typed into the Excel spreadsheet, located on
the PL’s computer, are password protected and saved on a USB flash drive. The USB is kept in
a locked file drawer located in the PL’s home office. At the end of the project, the paper
reminders and chart audit data will be kept in the PL’s home in a locked file drawer. The project
leader and EBP project advisor were the only people who had access to the data collected for
this EBP project.
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Table 3.1
Actual Timeline Fall 2018
Fall 2018 Semester Weeks

1

2

3 4

5 6 7

X

X

X X

X

8

9 1
0

1
1

1
2

1
3

1
4

1
5

X X

X

X

X

X

X

9 1
0

1
1

1
2

1
3

1
4

1
5

1
6

Empirical Phase
1. IRB approval

X X

2. Pre-intervention data
collection

X

3. Staff education
4. Intra-intervention data
collection
Fall 2018 Semester Weeks

1

2

3 4

56

5 6 7

8

1
6
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Table 3.2
Actual Timeline Spring 2019
Spring 2019 Semester Weeks

1

2

3 4

5 6 7

8

9 1
0

1
1

Empirical Phase continued
X

4. Intra-intervention data
collection continued

X X
X X

5. Post-intervention data
collection
Analytical Phase

X X X X

1. Entering data in SPSS

X
X X

2. Data Analysis

X

X

X X

X

X X

X

3. Interpretation of results
X X

4. Abstract preparation

X

5. Poster development
6. Finalizing paper
Dissemination Phase

X

1. Discussing project results
with stakeholders
2. Develop project
improvements
recommendations

X

3. Hand-off plan

X

4. Biography preparation

X

X X
X X

5. Abstract preparation

57

1
2

1
3

1
4

1
5

1
6
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X

6. Poster preparation

X X

X
X

7. Presentations/reports
8. Utilization of findings
Spring 2019 Semester Weeks

1

2

3 4

58

5 6 7

8

9 1
0

1
1

1
2

X
X

X

1
3

1
4

1
5

1
6
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CHAPTER 4
FINDINGS
Research has an imperative place in nursing. Through critical thinking and scholarly
writing, research leads DNP prepared nurses to conduct EBP projects which can be used to
improve the health of patients. The purpose of this EBP project was to alter standard practice
among HCPs, thereby improving adherence to CPGs for prescribing a statin and/or aspirin
among patients who have been diagnosed with dyslipidemia, HTN, and/or T2DM and have a
10-year ASCVD risk factor of greater than or equal to 7.5%, thereby potentially preventing
primary CVD in these at-risk patients. The PICOT question that guided this study is, “For
healthcare providers in a primary care setting, does incorporating a multi-modal approach that
involves education, computer-generated paper reminders at point of care, visual cues, and
ongoing feedback about prescribing performance improve the initiation of medication therapy for
the prevention of primary CVD in at-risk adult patients over a 7-week period?”
The interventions for this project included a multi-modal approach that included four
strategies:
1. Education was used to provide the latest CPGs to prevent primary CVD and about how
to create computer-generated paper reminders for at-risk patients.
2. The PCE was utilized to calculate at-risk patients 10-year estimated ASCVD risk factor.
Once the ASCVD computer-generated calculation was obtained, the office staff printed
out the calculation, wrote the patient’s medical record number in the upper right-hand
corner then made it accessible to HCPs during point of care visits.
3. For the visual cues, copies of the CPG flowchart were placed in each examination room
as a quick reminder.
4. Feedback was provided to HCPs on a weekly basis via letter format.

Participants
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Size. Participants included in this EBP project included one physician and two nurse
practitioners who have prescriptive authority. Descriptive characteristics for the participants
include one male and two females. To preserve anonymity, no further descriptive characteristics
will be provided.
To measure the outcome, the initial sample included 285 patient charts which were audited
during the EBP project. After assuring that patients included in the audit met the inclusion
criteria, the final sample consisted of 234. There were 76 of pre-intervention patient charts, 75
charts audited during the intervention, and 83 charts from the post-intervention audit.
Characteristics. Data were collected about the three HCPs who had prescriptive authority
regarding their prescribing a statin and/or aspirin in patients at-risk for primary CVD. Aggregated
data will be reported to protect anonymity. Data collected during the patient chart audits
included medical record number, gender, age, race, total cholesterol, LDL-C, HDL cholesterol, if
the patient is currently taking a statin and/or aspirin, the patient’s current blood pressure,
presence of a diagnosis of diabetes, if the patient is currently being treated for HTN, and
whether the patient is a current, former, or has never smoked. These data were necessary for
the PCE to calculate ASCVD risk factor.
Chi-square tests were used to determine if there were any statistically significant differences
between the pre-intervention, implementation and post-intervention groups on the variables of
gender and race. Results showed that there were no statistically significant differences between
the intervention groups on these variables.
The ages of patients ranged from 40 to 75, with an average of 58.21 years and a SD of
7.873 years. There were more females (65%) compared to males (35%). The sample was
primarily African American (98.7%), with two Caucasians (0.9%), and one Hispanic/Latino
(0.4%). Eighty-nine (88.9%) percent of patients had an ASCVD greater than or equal to 7.5
percent, (92.7%) had a diagnosis of hyperlipidemia, (88.9%) were taking HTN medication, and
(52.6%) had a diagnosis of which required a statin and/or aspirin to be prescribed (Table 4.1).
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Table 4.1
Patient Chart Audit Sample Characteristics
Variable

Pre-intervention
(n = 76)

Age Mean(SD)

56.87(8.646)

58.09(6.919)

Gender
Female

49(64.5%)

47(62.7%)

56(67.5%)

152(65%)

Male

27(35.5%)

28(37.3%)

27(32.5%)

82(35%)

Black

76(100%)

72(96%)

83(100%)

231(98.7%)

Caucasian

0(0%)

2(2.7%)

0(0%)

2(0.9)

Hispanic

0(0%)

1(1.3%)

0(0%)

1(0.4%)

Race

Implementation
(n = 75)

Post-Intervention
(n = 83)
59.55(7.814)

Total
(n = 234)

58.21(7.873)

Risk Factors*
ASCVD

65(85.5%)

71(94.7%)

72(86.7%)

208(88.9%)

Dyslipidemia

68(89.5%)

73(97.3%)

76(91.6%)

217(92.7%)

HTN

70(92.1%)

66(88.0%)

72(86.7%)

208(88.9%)

T2DM

42(55.3%)

33(44.0%)

48(57.8%)

123(52.6%)

*Includes comorbidities
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ASCVD. A patient’s 10-year ASCVD is based on a patient’s gender, age, race, total
cholesterol, LDL-C, HDL cholesterol, if the patient is currently taking a statin and/or aspirin, the
patient’s current blood pressure, if the patient has a diagnosis of diabetes, is currently being
treated for HTN and whether the patient is a current, former, or have never smoked. After the
patient’s data is input into the PCE, the 10-year ASCVD is obtained. Stone et al. (2013) state
that patients who have an ASCVD of greater than or equal to 7.5% should be started on a
statin; while the USPSTF (2016) recommends starting a statin and/or aspirin in patients who
have an ASCVD greater than or equal to 10%. Descriptive statistics were used to determine the
frequency and percentage of patients who had an ASCVD score greater than or equal to 7.5%.
The results revealed 208 out of 234 (89%) patients had a 10-year ASCVD risk factor that met
the criteria for this EBP project (Table 4.1). Results also revealed that 172 (73.5%) patients had
a 10-year ASCVD risk factor greater than or equal to 10%.
Dyslipidemia. High cholesterol was determined using an if statement to filter patients who
had a LDL-C greater than or equal to 70. Patient who had a LDL-C greater than or equal to 70
mg/dl have a diagnosis of dyslipidemia. Based on this criterion, the frequency of dyslipidemia
was 217 out of 234 (92.7%) patients (Table 4.1).
Hypertension. Clinical practice guidelines suggest patients who have a diagnosis of HTN
and an ASCVD greater than or equal to 10% should be treated appropriately with
antihypertensive medication(s) and started on a statin (Wheaton, 2016). Descriptive statistics
were used to determine the number of patients being treated for HTN. Eighty-nine percent (n =
208) was revealed to be receiving HTN treatment (Table 4.1).
Type II Diabetes. A history of T2DM was determined by auditing patient charts of the three
providers for this EBP project. Descriptive statistics were used to determine the number of
patients who had a diagnosis of T2DM. Nearly 53% (n = 123) of the patients were diagnosed
with T2DM treatment (Table 4.1).
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Changes in Outcomes
The primary question for this project was based on HCP compliance with prescribing a
statin and/or aspirin to patients who had a diagnosis of dyslipidemia, HTN, and/or T2DM and an
ASCVD greater than or equal to 7.5%. Findings show that there were improvements from the
pre-intervention phase to the implementation phase, while a slight decrease was noted from the
implementation phase to the post-intervention phase. The secondary outcomes examined
include the pattern of prescribing statins and/or aspirin, as well as comorbidities.
Primary Outcome: Compliance with CPGs.
During pre-intervention phase, data showed that the HCPs were compliant with
prescribing a statin or aspirin for 47.4 % (n = 36) of the patients and non-compliant with 52.6%
(n = 40) of the patients (Table 4.2). During the intervention, compliance increased nearly 20%
with a compliance rate of 66.7% (n = 50). Post-intervention data revealed a slight drop in
compliance to 63.9% (n = 53). Overall, HCPs were prescribing according to the CPGs for 59.4%
(n = 139) of the patients (Figure 4.1).
Because compliance was measured as a nominal level variable, a cross tabulation Chisquare was computed to determine if there was statistically significant improvement (Cronk,
2018). Results showed a combined statistically significant improvement between all phases for
compliance (X2 = 6.887, df = 2, p = 0.032) (Table 4.3).
Secondary Outcomes: Prescribing Trends.
Secondary analysis for this EBP project focused on the prescribing preferences of the
HCPs and the prevalence of comorbidities. According to this EBP project prescribers could
prescribe a statin, aspirin, or both to at-risk patients. Descriptive statistics show there was a
slight increase for prescribing statins and aspirin as the project progressed (Table 4.4). Fifty-five
(23.6%) patients were prescribed a statin; while 34(14.5%) patients were prescribed an aspirin,
47(20%) were prescribed combination therapy of a statin and aspirin and 98(41.9%) of patients
were not prescribed any medication therapy (Figure 4.2).
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Table 4.2
Compliance/Non-compliance
Variable

Pre-intervention
(n = 76)

Compliant

36(47.4%)

50(66.7%)

53(63.9%)

139(59.4%)

40(52.6%)

25(33.3%)

30(36.1%)

90(38.5%)

Non-compliant

Implementation
(n = 75)
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Post Intervention
(n = 83)

Total
(n = 234)
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Figure 4.1 HCP Compliance with Prescribing Statin and/or Aspirin
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Table 4.3
Compliance Chi-Square Tests

Pearson Chi-Square

Value
6.887a

df

Asymp. Sig.
(2-sided)
2
.032
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Table 4.4
Prescribing Trends

Statin

Pre-intervention
(n = 76)
13(17.1%)

Implementation
(n = 75)
21(28.0%)

Post-intervention
(n = 83)
21(25.3%)

Total
(n = 234)
55(23.5%)

Aspirin

10(13.2%)

12(16.0%)

12(14.5%)

34(14.5%)

Combined

15(19.7%)

13(17.3%)

19(22.9%)

47(20%)

None

38(50.0%)

29(38.7%)

31(37.3%)

98(41.9%)
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Figure 4.2 Prescription Preferences
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Table 4.5
Frequency and Percentage of Prescribing Choice based on Diagnosis

Statin

Dyslipidemia
(n = 217)
51(23.5%)

Hypertension
(n = 208)
47(22.6%)

T2DM
(n = 123)
34(27.6%)

Aspirin

32(14.7%)

31(14.9%)

14(11.4%)

Combined

41(18.9%)

45(21.6%)

37(30.1%)

None

93(42.9%)

85(40.9%)

38(30.9%)
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Figure 4.3 Frequency and Percentage of Prescribing Choice based on Diagnosis
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Descriptive statistics were used to breakdown HCP prescription preference for each atrisk category used for this project to prevent primary CVD. Prescription preference include statin
only, aspirin only or a combination of both based on patient’s diagnosis and ASCVD risk factor.
Dyslipidemia. Stone et al. (2013) recommends initiating a statin in patients who have a
primary LDL-C of 190mg/dl with no 10-year ASCVD risk factor or patients who have an LDL-C
greater than or equal to 70 mg/dl through less than or equal to 189 mg/dl with a 10-year ASCVD
risk factor greater than or equal to 7.5%. Dyslipidemia was analyzed using descriptive statistics
about patients whose chart audits revealed 217 had a LDL-C greater than or equal to 70mg/dl
(Table 4.5). Analysis of HCPs prescription preference revealed that 51(23.5%) were patients
treated with statin alone, 32(14.7%) aspirin alone, and 41(18.9%) treated with a statin and
aspirin; while 93(42.9%) of patients with dyslipidemia did not receive appropriate medication
therapy (Figure 4.3).
Hypertension. Whelton et al. (2018) and Arnett et al. (2019) recommend initiating statin
therapy in patients who have a diagnosis of HTN and a 10% or greater 10-year ASCVD risk
factor. Descriptive statistics revealed 208 patients were being treated for HTN. Thirty-seven
(22.6%) patients in this diagnosis category were treated with a statin only, 31(14.9%) patients
received an aspirin only, and 45(21.6%) patients were prescribed both a statin and an aspirin
regimen; while 85(40.9%) did not receive either medication therapy. Table 4.5 and Figure 4.3
display the frequency and percentage of prescribing choice based on diagnosis.
Type II Diabetes Mellitus. Stone et al. (2013) recommended that patients who have a
diagnosis of T2DM and a 10-year ASCVD risk factor of greater than or equal to 7.5% should be
prescribed a moderate or high intensity statin. Data showed 123 patients had diagnosis of
T2DM. Of these, 34(27.6%) patients were prescribed statins, 14(11.4%) of the patients were
prescribed aspirin, and 37(30.1%) patients received a combined treatment regimen of a statin
and an aspirin; while, 38(30.9%) of patients with T2DM did not receive appropriate medication.
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Table 4.5 and Figure 4.3 displays the frequency and percentage of prescribing choice based on
diagnosis.
Instrument Reliability and Validity
The reliability and validity of the PCE instrument has been established (Emdin et al.,
2016 and Khalili et al., 2015). Cronk (2018) states instruments must be tested for reliability
before determining validity. Validity of the PCE was tested using the Pearson correlation. A
Pearson correlation was calculated examining the relationship between patient’s ASCVD and
HCP compliance. No correlation was found (r = -0.079, p > 0.01). See Table 4.6 for the validity
correlation table.
Significance
Significance and interpretation of the results is vital to determine whether implementation
of the EBP project successfully changed practice. There was a statistically significant
improvement in HCP compliance to prescribing a statin and/or aspirin in patients who were
diagnosed with dyslipidemia, HTN, and/or T2DM. Descriptive statistics were calculated
regarding statin and aspirin prescribing throughout this EBP project. Statistics showed improved
HCP compliance with prescribing both statins and aspirin as the project progressed. Data did
not show a provider preference for either statins or aspirin.
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Table 4.6
Validity Correlations

What is the
patients
ASCVD?
What is the patient’s
ASCVD?

Is the provider
compliant?

Is the patient currently
on a statin?

Is the patient currently
taking aspirin?

Pearson
Correlation
Sig. (2-tailed)
N
Pearson
Correlation
Sig. (2-tailed)
N
Pearson
Correlation
Sig. (2-tailed)
N
Pearson
Correlation
Sig. (2-tailed)
N

**. Correlation is significant at the 0.01 level (2-tailed).
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Is the patient
Is the patient
currently
currently on a
taking
statin?
aspirin?

Is the
provider
compliant?
1

-.079

-.097

-.074

234

.231
234

.137
234

.260
234

-.079

1

.727**

.492**

.231
234

234

.000
234

.000
234

-.097

.727**

1

.212**

.137
234

.000
234

234

.001
234

-.074

.492**

.212**

1

.260
234

.000
234

.001
234

234
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CHAPTER 5
DISCUSSION
Doctor of nursing prepared nurses demonstrate expertise when evaluating EBP projects
by discussing statistical significance and providing recommendations for future implications.
This provides information for future EBP projects and evidence-based bedside care. Providing
insights about the framework, strengths, and limitations about the current project saves time for
future nurses who to attempt a different path. The purpose of this EBP project was to alter
standard practice among HCPs, thereby improving adherence to CPGs for prescribing a statin
and/or aspirin among patients who have been diagnosed with dyslipidemia, HTN, and/or T2DM
and have a 10-year ASCVD risk factor of greater than or equal to 7.5%, thereby potentially
preventing primary CVD in these at-risk patients. It answers the PICOT question: “For
healthcare providers in a primary care setting, does incorporating a multi-modal approach that
involves education, using computer-generated paper reminders at point of care, visual cues,
and ongoing feedback about prescribing performance improve the initiation of medication
therapy for the prevention of primary CVD in at-risk adult patients over a 7-week period?” This
chapter presents a culmination of this EBP project.
Explanation of Findings
Primary Outcome
Data analysis showed there was a statistically significant increase (X2 = 6.887, df = 2, p
= 0.032) in the prescribing of a statin and/or aspirin in at risk patients when using a multi-modal
approach for prescribing a statin and/or aspirin in at-risk patients. There was a nearly 20%
increase with HCPs prescribing statins and/or aspirin in at-risk patients from the pre-intervention
phase to the implementation phase of this EBP project. However, a slight decrease was noted
with compliance prescribing a statin and/or aspirin from the intra-intervention phase 66.7%
compliance to the post-intervention phase 63.9% compliance. These findings are congruent with
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findings of a previous study completed by Arditi et al. (2017) showing that computer generated
reminders delivered on paper moderately improved CPG compliance; however, the authors did
not report if improvement continued during the post-intervention phase of any of the research
they reviewed. Fiks et al. (2015) reports that 11% of HCPs who used the CDS tool during the
implementation phase trial period did not use it afterwards. These findings are congruent with
this EBP project in that there was slight drop in adherence rates from the implementation phase
to the post-intervention phase.
It has been shown that when computer reminders are combined with other interventions,
slight improvements with the adherence continued to improve when computer reminders are
used (Shojania et al, 2009). Even more improvements were noted when hard stops are used in
the ERM system (Shojania et al., 2009). When reminders are placed in computer systems, CPG
adherence will increase (Zahanova et al., 2017). When general practitioners used the electronic
optional guidelines as a tool to refer patients to specialize care continued to use it during the
evaluation phase (Rokstad et al., 2013); however it has also been suggested that highlighted
printed reminders were unsuccessful in improving HCPs responsiveness (Hendrix et al., 2015).
These results are not congruent with the findings from this EBP project because there was an
increase in compliance when using the paper reminders combined with other cues.
In this EBP project, the issue with using the recommended best practice of computer
reminders was an organizational barrier. If computer reminders could be placed in the EMR
system, with or without hard stops, higher compliance rates with CPGs may have been
achieved. This approach would have eliminated reliance on medical assistants, who were
resistant to the added responsibility of completing the PCE. The prompt would have
automatically filled in all the data necessary to run the PCE and provided HCPs with patients
10-year ASCVD risk factor.
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Despite not using computer prompts, the improvement of compliance with CPGS by
HCPs from the pre-intervention phase to the implementation phase are primarily attributed to
the multi-modal intervention. However, there are some other factors that could also explain the
increased compliance. For example, the project liaison is an employee at the project site and
was very supportive when resistance to completing the PCEs was met. The PL taught the
project liaison how to complete the PCEs; however, it is uncertain if the project liaison began
completing the PCEs for patients encountered. The PL was present at the project site more
often to ensure patients who met the requirements for having PCEs completed and given to the
HCP were complete. The PL also helped performed PCEs and provide them to the HCPs to
ensure successful implementation of the this EBP project.
While there was a slight drop in compliance from the intervention phase (66%) to the
post-intervention phase (63%). Some other factors that could explain this drop include: (a) lack
of oversight by the PL, (b) disagreement with CPGs, (c) non-compliance by patients because of
medication side effects, (d) HCP not appreciating statins because of side effects, and (e)
prescribing contraindications based on patient factors. Despite the slight drop, compliance
during the post intervention phase remained well above the pre-intervention phase (46%). This
provides evidence that the multi-modal intervention had some lingering effect on the prescribing
compliance of the HCPs.
Secondary Outcomes
Prescribing trends. The secondary outcome focuses on the prescribing trends of
HCPs. The PL calculated the prescribing trends of HCP for the prevention of primary CVD in atrisk patients. Prescribing of statins, aspirin, or both by the HCPs slightly increased from preintervention to post-intervention. However, it was noted, there was no difference in prescribing
preferences between the pre-intervention, implementation, or post-intervention phase related to
statin, aspirin, or both (Table 4.4).
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Comorbidities. The incidental findings question for this EBP project was “how many
patients in the clinic where this EBP project was conducted and whose charts were audited had
multiple co-morbidities?” The purpose of this question was two-fold: (a) to compare this data to
the national and state average, and (b) to evaluate the need for future DNP projects to be
performed in the community. When considering these purposes within the context of this EBP
project, it is important to keep in mind that patients in the sample were primarily African
American.
Dyslipidemia, HTN and T2DM are risk factors for primary cardiovascular disease (CDC,
2012, 2017; Healthy People 2020, 2014). Oftentimes, HCPs care for patients who have multiple
co-morbidities. In this EBP project, 38% (n = 89) of patients had a diagnosis of dyslipidemia,
HTN, T2DM and an ASCVD greater than or equal to 7.5%. Forty-one percent (n = 96) of
patients had a diagnosis of HTN, T2DM and an ASCVD greater than or equal to 7.5%. While,
43% (n = 101) had a diagnosis of dyslipidemia, T2DM and an ASCVD greater than or equal to
7.5%. Seventy-six percent (n = 178) had a diagnosis of dyslipidemia, HTN and an ASCVD
greater than or equal to 7.5%. Although there appears to be an alarming number of patients at
this project site with multiple co-morbidities that can lead to further health complications it is
misleading because the population chosen were patients with a history of dyslipidemia, HTN,
and T2DM. It is important to note that, although data is reported about individuals with
dyslipidemia, HTN, and T2DM, selection bias exists in this EBP project. No data exist that
depicts the national or states level of individuals with multiple comorbidities.
Health disparities. Data from this EBP project shed light on the urgency to prevent
primary cardiovascular disease in these at-risk patients, most all of whom were African
American. In a survey conducted by the CDC (2017d) health disparity was measured by asking
patients if they had ever been informed by their HCP that they had one of the risk factors for
primary CVD.
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Dyslipidemia. Health disparity data collection was conducted by asking patients if they
had ever been informed by their HCP that they had one of the risk factors for primary CVD
(CDC, 2017b). According to the America’s Health Rankings (2018a), in 2018 there was a
decrease in the number of individuals who were diagnosed with dyslipidemia in the US (34.1%)
and in Indiana (33%). Dyslipidemia was noted to increase with age nationally and in Indiana.
Approximately 41% of individuals ages 45-64 in the U.S. and 41.7% of those in Indiana have a
diagnosis of dyslipidemia; while those 65 and over 51.7% in the US and 54.1% in Indiana.
African American rank number three 30.8% US and 28.5% in Indiana for being diagnosed with
dyslipidemia with American Indian/Alaskan Native and the Asian population ranking higher.
Selection bias exist; therefore, the PL is unable to compare the data from this EBP project to the
national or state average. Doctor of nursing practice nurses must be aware that it is
recommended patients be started on a statin in the current CPGs if they have a LDL-C of 190 or
greater and if they have a LDL 70-189mg/dl and an 10-year ASCVD of 7.5% or greater.
HTN. According to the CDC (2017c), 29.0% of individuals in the United States and
48.6% in Indiana had a diagnosis of HTN. The prevalence of HTN increases with age and is
higher among African Americans. Data reveal that 7.5% of adults aged 18–39 (CDC, 2017c)
while American Health Ranking (2018c) reports 14.1% among 18-44 in the US and 16.2% in
Indiana, 33.2% among those aged 40–59 (CDC, 2017c). American Health Ranking (2018c)
reports in ages 45-64 40.5% in US while 44.6% in Indiana and 63.1% among those aged 60 and
over have HTN (CDC, 2017c) while 60.5% of individuals over 65 in the US and 62.8% in Indiana
have a diagnosis of HTN. Racial disparity was noted with patients diagnosed with HTN.
Approximately 41% of African Americans in the U.S. while 45.6% in Indiana was noted to have
HTN (America’s Health Rankings, 2018c), 29.7% of Caucasians, 28.7% of Asians and 27.3% of
Hispanics (CDC, 2017c). Hypertension has a crucial role in the prevention of primary CVD. DNP
prepared nurses must prescribe the appropriate antihypertensive medications to patients,
discuss lifestyle changes and initiate a statin for preventative measures.
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T2DM. Diabetes diagnosis have shown an increase every year since 2011 (CDC,
2017d). Centers for Disease Control (2017d) reports that 30.3M(9.4%) individuals had diabetes
and these statistics increase with age. Seventeen percent of individuals age 45-64 years and
25% older individuals older than 65 have a diagnosis of diabetes (CDC, 2017d). African
Americans make up 12.7% which is the second highest prevalence nationality with American
Indians and Alaska Native first at (15.1%) (CDC, 2017d). Approximately 12% of US individuals
have a diagnosis of diabetes (America’s Health Rankings, 2018b). As with HTN, diabetes
diagnosis increases based on age. Individuals aged 18-44 2.9% in the US while 3.2% in
Indiana, aged 45-64 14.5% in the US vs 16% in Indiana and individuals older than 65 who have
a diagnosis of diabetes 22.6% vs 24.4%. African Americans in the US with diabetes are 14.3%
while 14.8% in Indiana (America’s Health Rankings, 2018b). Doctor of nursing practice prepared
nurses with the inclusion of patients, must maintain a hemoglobin A1C of less than 6.5 mg/dl to
prevention T2DM from occurring or control T2DM levels.
Health disparity for this EBP project. Statistics for these health disparities may be
higher in the region of the Midwestern region this EBP project was conducted because it was
conducted in a low socioeconomic and low-income urban community. This area has no healthy
grocery stores; therefore, patients are limited in what they can buy if they do not have
transportation out of their community. The community has numerous fast-food and unhealthy
restaurants in the area but no healthy options. Others may be on a fixed-income and must
choose between healthy eating, medication, or shelter. Although, patients can exercise in their
homes or walk around their neighborhoods, they may not feel safe. There is only one fitness
center in the community but is not fully equipped with proper exercise equipment.
Another aspect that must be considered is patient compliance. Patients may be in denial
about the diagnosis they were given by their HCPs. Patients may be accustomed to eating in a
particular manner and are not willing to change. They are not willing to take medications
prescribed to them because of medication side effects, disbelief in the diagnosis, or affordability.
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Lack of health literacy or lack of understanding about medications, diagnoses are contributing
factors that play a role in the health disparities in this community. Lack of insurance and lack of
trust with the healthcare system can account for another reason for the increase amount of
health disparities in this community.
Doctor of nursing practice prepared nurses are in a unique position to assist with
combating these health disparities in this community. Doctor of nursing practice practitioners
must educate patients about their risk for primary CVD. Several EBP projects can be initiated
from information provided in the findings. An extension of this EBP project can involve
examination of patient compliance with taking prescribed statins and/or aspirin. There has been
a substantial amount of data evaluating the use of cellular phone and medication compliance.
For example, Palmer, Barnard, Perel, and Free (2018) conducted a study about preventing
primary CVD in at-risk patients through medication adherence using mobile devices. Doctor of
nursing practice prepared nurses can setup a health fair in the community or at a church to
evaluate patient’s risk for health disparities. The DNP prepared nurse can setup exercise
sessions at the church or in a community center that is easily accessible for individuals in this
community.
New CPGs (Arnett et al., 2019) for the prevention of primary CVD were recently
released. It is imperative that DNP prepared nurse practitioners are aware and knowledgeable
of these CPGs to prevent primary CVD in at-risk patients. The CPGs state that a discussion
regarding moderate-intensity statin should be initiated in patients who are considered borderline
risk primary CVD (have a PCE of 5% to less than 7.5%) and a LDL-C of greater than or equal to
70 mg/dl to less than 190 mg/dl (Arnett et al., 2019). However, patients who are intermediate
risk (PCE of greater than or equal to 7.5% to less than 20% and a LDL-C of great than or equal
to 70 mg/dl to less than through less than 190 mg/dl) must have a moderate intensity statin
initiated (Arnett et al., 2019). Patients who are high risk (PCE greater than or equal to 20% and
a LDL-C of great than or equal to 70 mg/dl to less than 190 mg/dl) must have a statin initiated,
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but the researchers do not state whether the statin should be moderate or high intensity (Arnett
et al., 2019). Patients who have a LDL-C greater than or equal to 190 mg/dl regardless of risk
factors should have a high-intensity statin initiated (Arnett et al., 2019). Discontinuing the routine
use of aspirin for the prevention of primary CVD is recommended in patients older than 70 years
old because the risk of bleeding outweighs the benefits (Arnett et al., 2019). However, patients
40-70 years of age and who have a high ASCVD risk factor and a low risk of bleeding can
continue aspirin daily if recommended by their HCP. Doctor of nursing practice nurse
practitioners must consider all factors when considering sources of information when patients
present to their office with information they have heard or read. Information heard from the news
or friends can be misconstrued; therefore, it is imperative that DNP nurse practitioners are well
informed of CPGs and educate patients with facts of information presented. DNP prepared
nurses must also consider the risk versus benefits ratio when prescribing medications to
patients.
Theoretical Framework
Kotter’s 8-Step framework (Kotter, 2012) was used to guide this EBP project. Kotter’s
framework focuses on leading change in organizations; however, it has been utilized in several
settings including nursing. When using Kotter’s (2012) 8-step change model it must be
understood that it is broken down into three phases. Phase one is the defrost phase which the
transformation process is occurring which includes steps 1-4, phase two is the introduction and
implementation of new changes which includes steps 5-7, and phase three includes continuing
the change process and anchoring it in place to make it stick.
Strengths in the theory that it is detailed and guides one through the process of each
step by providing examples of successes and failures to change. Kotter (2012) clearly advises
users of the change model that attempts to skip steps will result in failure to change practice.
“The first step in putting together the kind of team that can direct a change effort is to find the
right membership” (Kotter, 2012, p. 57). While there is evidence showing that reminders
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included in EMR systems improves adherence by HCPs (Fiks et al., 2015; Rokstad et al., 2013;
Shojania et al., 2009; Zahanova et al., 2017), individuals at the organization where this EBP
project was conducted did not allow the PL to make changes to the EMR system. The PL was
informed that changes would disrupt the entire organization including outpatient physician
offices. Therefore, the PL had to implement computer-generated reminders printed on paper.
This process included setting up a coalition to lead to project. This was discussed and
demonstrated with the medical assists about completing the PCEs, which generate the 10-year
ASCVD risk factors. Prior to implementation, the PL established a sense of urgency by
providing education to all the team players of the project. Education was provided about the
prevalence and cost of CVD in the U.S. The second step, creating the guiding coalition, proved
to be a challenge for the PL. At the beginning of the project, the medical assistants stated they
would assist with the project by completing the PCEs. This was a major aspect of this EBP
project because without this information, the HCPs would not know whether their patients
needed a statin/aspirin prescription. Medical assistants were the gatekeepers of this EBP
project. As the PL progressed through the next steps by developing the vision and strategy and
communicating the change vision to the team players, medical assistants were initially excited
and happy to perform the task. However, during the implementation phase of this project the
medical assistants resisted the change by not wanting to run the 10-year ASCVD calculations
using the PCE. During week two of this EBP project, the medical assistants did not run any
PCEs. Kotter (2012) states that reinforcement of previous phases needs to occur as one
progresses to other phases. In response, the PL reinforced previous steps by reeducating the
medical assistants on the importance and urgency of this EBP project in this community. During
the next step, to empower board-based actions the PL educated and encouraged the medical
assistants to replace the status-quo by completing the PCEs (Kotter, 2012). The PL continued
to empower the medical assistants through encouragement and motivation by informing the
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medical assistants that they are a part of a great project that will help with patient outcomes and
prevent primary CVD in at-risk patients.
Afterwards, the momentum increased, the medical assistants began performing the
PCEs again; however, the PL began coming to the site more often to ensure the PCE were
being performed and assisting with the PCE. Despite these efforts, resistance began shortly
afterwards. Based on the chart audits and the weekly collection of the printed computergenerated reminders printed on paper, the PL knew whether the PCEs were being performed.
Ivers et al. (2009) suggested that important improvements are noticed in patient outcomes when
audit and feedback are used; therefore, the PL provided weekly feedback in letter format on the
progress of the EBP project and how many patients received medication to prevent primary
CVD. Kotter (2012) stated, when generating short term wins, plans should be made for
improvements and wins must be celebrated visually when creating change. An incentive of
monthly lunches was provided twice during this EBP project to celebrate short-term wins of the
PCE being performed and the goal of the project being met because audits revealed HCPs
were prescribing a statin and/or aspirin to at-risk patients. In a study to evaluate incentive
effectiveness on lipid levels the researchers found that financial incentives were more
successful when patients and physicians jointly worked to decrease lipid levels in which both
received an incentive (Asch et al., 2015). When working independently to receive an incentive
for decreasing lipid levels there was not much success (Asch et al., 2015). It must be explained
that when providing incentives for short-term wins, it means that the project is progressing well
but has not made it to fruition. Although the lunch incentives did not improve the resistance met
by the medical assistants, the PL would continue to generate short-term wins if this EBP project
was performed again because it shows appreciation.
Steps seven which are consolidating gains and producing more change, and eight
anchoring new approaches in the culture (Kotter, 1996, 2012) were not established for this
project. During week seven of the project, the physician called the PL into the office and
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informed the PL that the medical assistants could no longer perform the PCEs. The project was
abruptly ended because of the resistance and complaints from the medical assistants and the
office manager. If the PL had to complete this EBP project again, Kotter’s 8-step change theory
would be used again; however, the PL would not rely so heavily on the medical assistants as
the gatekeepers to perform the PCE for at-risk patients. The PL would work harder and be more
convincing to the stakeholders that best evidence shows computer reminders placed in EMR
systems is the best evidence for improved patient outcomes and HCP adherence with
prescribing a statin (Fiks et al., 2015; Rokstad et al., 2013; Shojaina et al., 2009; Zahanova et
al., 2017).
The timeframe of this project did not make this theoretical framework conducive for this
EBP project because it was completed in 7 weeks. Kotter’s (2012) theoretical framework may
have been successful if the EBP project would have been conducted over 12 weeks as
originally planned. Therefore, with the ability to utilize best evidence-based practice in the EMR
to ensure HCP adherence to prescribing a statin and/or aspirin, a longer timeframe would also
be considered.
EBP Framework
Promoting Action on Research Implementation in Health Services framework was
utilized as the EBP framework to guide this EBP project. According to Kitson et al. (1998),
evidence, context, and facilitation leads to successful implementation of moving research to
practice. The PARiHS framework was a staple for this EBP project. It helped the PL focus on
the literature and discover the best strategies to change the practice of HCPs following CPGs
for the prevention of primary CVD in at-risk patients. However, the context and culture of the site
where the project was conducted was not conducive for this project. The context lacked
appropriate leadership to establish effective teamwork amongst team players to assure this
practice change. Evaluation was provided on a weekly basis through feedback in a letter to
each HCP and medical assistant about the success and/or necessary improvements.
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Facilitation was established by providing an educational session about the importance of
primary prevention of CVD. Facilitation is similar to Kotter’s step 2 establishing a guiding
coalition which is establishing the key players to move this EBP project forward. Resistance
ensued during the implementation phase of this project by the medical assistants. This
resistance made the PL go to the project site more often to ensure the PCEs were being
performed. The PL provided another educational session with the medical assistants to
empower them with the knowledge and to understand of the urgency of this EBP project. A
holistic approach for facilitation was attempted by providing the medical assistants with what
was needed for the successful implementation of this EBP project. If the PL had to conduct this
EBP project again, the PARiHS would be utilized again. With the proper leadership and the right
gatekeepers, research can be moved to clinical practice. Doctor of nursing practice nurses must
understand that plans may not always lineup accordingly but with continued effort change can
be made and the PARiHS model has all the tools to assist with successful implementation.
Strengths and Limitations of the EBP Project
Strengths
The prevalence and cost of CVD, as well as the CPG recommendations about
prevention of CVD, was established with education. Knowledge was established, as a result of
the education provided about the PCE and the meaning of the 10-year ASCVD calculation.
Although, this EBP project was met with resistance by the medical assistants, there was
improvement of compliance with prescribing statins and/or aspirin to at-risk patients (see Table
4.2). With the implementation of this EBP project, HCPs are aware of CPGs to prevent CVD in
at-risk patients. Healthcare providers are aware of the PCE to calculate patients 10-year
ASCVD risk factor to evaluate if a statin is necessary for at-risk patients. Based on the number
of patients with multiple co-morbidities, HCP can emphasize medication compliance, healthy
diet and exercise with their patients at each point of care visit. Healthcare providers can ensure
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patients bring in their medication bottles at each point of care visit to ensure medications are
being taken and patient do not have any questions about medications.
Limitations
Change is inevitable in whatever establishment one is employed; however, it is one of
the most difficult tasks to achieve. There were two major limitations to this project: (a) resistance
to using computer generated reminders in the EMR, and (b) resistance by the medication
assistants to performing the PCEs.
The inability to utilize best practice evidence which is creating hard stop computer
prompts in the EMR system as a reminder for HCP to prescribe a statin and/or aspirin in at-risk
patients was a limitation for the EBP project. This implementation would improve adherence
with CPG recommendation to prevent primary CVD. Resistance with the medical assistants
performing PCEs would not have presented a problem and the project would have had greater
success rates with prescribing a statin and/or aspirin. Staff at this facility have established a
routine. The staff did not prefer any new tasks that hindered that routine. This EBP project
encountered resistance from the medical assistants to perform the PCEs to obtain patients 10year ASCVD risk factor as time progressed. The project site did not have many employees to
assist with completing the PCEs. Another consideration is that the clinical site is a walk-in clinic.
On physician days, this site can see approximately 50 patients per day; therefore, the medical
assistants expressed they did not have time to run the PCEs. The limited timeframe of 7 weeks
to complete this EBP project was a limitation.
Implications for the Future
When EBP projects are completed, DNP practitioners should give thoughtful consider to
providing recommendations about practice, theory, education, and research. Informing others
about these implications is vital for establishing strategies to assist with following CPGs.
Practice
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Doctor of nursing practice nurses must consider establishing a protocol to utilize the
PCE for the prevention of primary CVD in at-risk patients. It would behoove organizations to
implement hard stops in the electronic medical records which automatically input the data once
the PCE is clicked. This would assist with HCPs to assess whether a statin is indicated for the
primary prevention of CVD. It must also be considered that a best practice alert be established
as a 5-year reminder about repeating the PCE. Doctor of nursing practice nurses must not pick
and choose which CPGs are best for their clients but be open to all evidence-based CPGs.
They must remain vigilant that all patients are unique and if a side effect occurs in one patient it
does not mean it will occur in another patient.
Doctor of nursing practice nurse practitioners have an important role as educators.
Doctor of nursing practice practitioners must educate patients on the importance of medication
adherence and possible health disparities that will can occur from not complying with
medications. Oftentimes, medication compliance is an issue because of lack of education of
what to expect. Therefore, patients must be educated about what side effects to expect when
taking statins or aspirin. When patients are educated about what side effects to expect they are
more inclined to comply with medications. It is important to establish safe open provider/patient
relationships, so patients feel comfortable telling their clinician when issues with medications
arise. It is essential that DNP prepared practitioners evaluate issues encountered with
medications at each point of care visits. When issues are encountered with patients taking a
medication it is the HCPs responsibility to begin an alternative therapy to ensure the prevention
of primary CVD.
Comorbidities are plaguing the community where this EBP project was conducted.
These comorbidities will lead to primary CVD if not addressed properly. Placing DNP prepared
nurses in a position to establish programs to assist patients with preventing comorbidities that
lead to primary CVD is a suggestion that will combat comorbidities. Doctor of nursing practice
prepared practitioners can create community health and wellness fairs, educational sessions,
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group programs, and complete home phone calls to combat the comorbidities that lead to
primary CVD in the community where this EBP project was conducted. Consideration must be
given to all participants when attempting to establish change because each party plays a vital
aspect to bringing successful change to an establishment.
Theory
One role of the DNP practitioner is to find the best theories to guide EBP projects. As
stated above, Kotter’s (2012) 8- step change model was not conducive to this EBP project
because of the time constraints. Kotter’s (2012) states, in his 8-step change model, failure to
change is because individuals do not take the time to continually reinforce early stages as the
change process moves to the next step. It is essential that step one through four are
foundationally set before the new changes can be successfully implemented (Kotter, 2012). The
PL educated and reinforced the purpose and importance of this EBP project as a sense of
urgency in step five empowering broad-band action. The medical assistants expressed an issue
with the high number of patients being seen in the office on the days the physician was in the
office; however, the PL noticed the PCEs were not being performed when the physician was not
in the office. This led to the PL coming into the office more frequently to assist with completing
PCEs, but change was met with resistance. The medical assistants were resistant to change
because of the status-quo established at this project site and lack of leadership from the office
manager and the physician not being acceptive of statin treatment in patients because of the
side effects. Although, Kotter’s 8-step change model was not successful at this project site,
there a high probability that it would have been successful if hard stop computer reminders were
placed in the EMR system for HCP’s to order a statin and/or aspirin to prevent primary CVD in
at-risk patients.
The PARiHS model (Kitson et al., 1998) was conducive for this EBP project; however,
the PL was unable to move research to practice. The culture of the project site is task driven
any deterring from the original tasks was not conducive. There was a lack of leadership at this
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project site which is necessary for success implementation. When resistance was met, the
leaders did not tell the medical assistants to continue the project but instead sided with the
medical assistants which lead to the EBP projects abrupt ending. The inability to implement the
best evidence-based practice for this EBP project hindered the evidence portion of the PARiHS
model elements. Lack of facilitation of the organization to incorporate computer reminders into
the EMR system for this EBP project was another reason for unsuccessful implementation. The
process of incorporating computer reminders into the EMR system would have made
implementation easier and facilitation would have been achieved. When using the PARiHS
framework all elements and many of the subelements must be in place to ensure successful
implementation. With the implementation of the best EBP the PL would use the PARiHS
framework again.
Research
Research regarding aspirin and statins have changed since the inception of this EBP
project. Therefore, prescribing practices should be updated with most recent recommendations
used. It is recommended that future research could focus on patient compliance with taking a
statin as prescribed be evaluated as an outcome. Another recommendation is that when a
similar project is implemented at a larger clinical site, comparisons between NP and physician
prescribing patterns also be evaluated to determine who is more compliant with following CPGs
to prevent primary CVD in at-risk patients. It is also recommended that this project be changed
to include hard stops in the electronic medical records system to alert practitioners to complete
the PCE to obtain 10-year ASCVD risk factors and initiate a statin for at-risk patients as
recommended in the latest CPGs. The PL recommends conducting post-intervention collection
data from medical records of patients who had the PCE completed during the implementation
phase instead of randomly selecting patients.
Researchers postulated that CPGs were not being adhered to because they were too
long and confusing (Alexander et al., 2016; Barth et al., 2016; McKee et al., 2017). It must be
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noted that the researchers for the 2019 ACC/AHA Guidelines on the Primary Prevention of CVD
created a Guidelines Made Simple version for ease of use and readability for HCPs and
patients. The Guidelines Made Simple version will help with the barriers (Alexander et al., 2016;
Barth et al., 2016; McKee et al., 2017) of HCPs adhering to CPGs. The Guidelines Made Simple
version was decreased from 89 pages to 17 pages and flowcharts are present for each at-risk
category for ease of flow. These flowsheets (Appendix B) can be printed out and placed in each
examination room as a reminder for DNP prepared practitioners to utilize and follow the
recommended CPGs for better patient outcomes. The Guidelines Made Simple version will
assist DNP prepared practitioners educate patients about the most recent recommendations
available for the prevention of primary CVD.
The validity and reliability of the PCE has been questioned by several researchers
because it provides an overestimated 10-years ASCVD risk factor score in certain populations
(Emdin et al., 2016; Khalili et al., 2015). The authors of these studies suggest calculating 10year ASCVD scores improves after recalibration of the PCE (Emdin et al., 2016; Khalili et al.,
2015). Although, the criticisms are founded, the AHA and ACC continues to advise the use of
the PCE for the calculation of patients 10-year ASCVD every 5-years. In the 2019 ACC/AHA
Guidelines on the Primary Prevention of CVD, (Arnett et al., 2019) recommend continuing to
utilize the PCE although it is known to overestimate and underestimate patients 10-year ASCVD
risk factor. Therefore, patients who have a borderline or intermediate risk factor for primary
ASCVD must have other risks evaluated prior to initiating statin therapy.
Education
It is imperative that schools of nursing educate nurses in leadership skills which include
transformational change. It must be ingrained in nursing students early that change is difficult to
establish when organizations and individuals in the organization are accustomed to practices
being status-quo. Nursing is an innovate field of study which needs nurses who are willing to
champion the challenge of change. For example, Fridman (2014) conducted a lived-experience
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study about oncology nurse’s experiences with EBP project. During this project several themes
were noted. A nurse stated that she felt empowered by the process of challenging the status
quo; while, another was mesmerized by the EBP project process – she stated, she had never
participated in an EBP project because she only had her bachelor’s degree. For example,
schools of nursing could incorporate a class that pairs undergraduate senior students with a
DNP student to collaborate on an EBP project. This will expose undergraduate students to the
DNP process and prepare them to be the change agents nursing needs to incorporate research
to practice.
In nursing graduate curricula, pharmacology and assessment classes can include a
discussion about CPGs to prevent CVD in all patients. Students are then exposed to the idea of
the PCE and the ability to download the application to their mobile devices. Doctor of nursing
practice prepared students are in a unique position to learn about the health disparities that
plague the community where they live. Service projects can be completed to combat, educate
and empower individuals of the community to change to a healthy lifestyle.
An educational PowerPoint was used to provide a since of urgency and share the vision
for this EBP project. The educational sessions were performed separately because the HCPs
rotate between two offices. Initially, all team players were excited to be assisting in this EBP
project. Questions were answered, and the PL was available to answer questions throughout
the implementation phase and daily during the first week. Education about HCPs not adhering
to CPGs, statistics about CVD, and CPG implementation strategies can be used in various
formats. Various educational formats can be used by the DNP practitioner to provide education
about the latest evidence-based CPGs. Educational formats available include PowerPoints in
Health stream, face to face education, or lunch and educate. All staff members need to be
included in the education about preventing primary CVD and the best strategies to create a
successful change. If resistance occurs during the educational stage, it needs to be addressed
at that time so that cohesiveness can be established, and all fears and hesitancies are

91

PREVENTING PRIMARY CVD: CPG COMPLIANCE

92

addressed. Successful implementation is curial, and it begins with education and getting all
stakeholders on board.
Conclusion
Computer-generated reminders printed on paper and provided to the HCP at point of
care visits showed a 20% improvement in compliance with HCP prescribing a statin and/or
aspirin to at-risk patients despite resistance by the gatekeeper. Clinical decision support
systems and EMR alert systems have been shown to be the best intervention for HCPs to
adhere to recommended guidelines. Results from this EBP project reveal that it is critical for
DNP practitioners to use the best evidence available when conducting EBP projects.
Organizations must remove factors which prevent the use of best practice by settling for other
options, they may introduce unintended barriers to achieving the best possible patient care. The
Kotter’s (2012) change model and PARiHS (Kitson et al., 1998) model was used to guide this
EBP project to provide the necessary tools and guidance to bring this project to fruition
successfully. When using Kotter (2012) 8-step change model, establishing a strong coalition
who knows and understands the vision and goals of the EBP project is essential. Dependability,
accountability, and responsibility lie with the gatekeepers and therefore, they are able to impede
the progress of the EBP project. Successful implementation of an EBP project relies on the
gatekeeper but more importantly the stakeholder’s willingness to incorporate the best evidencebased practice for change to occur.
It is imperative that the primary prevention of CVD is important to every DNP prepared
practitioner. Doctor of nursing prepared practitioners must remain vigilant life-long learners
because of the fast-paced innovative changes in healthcare. Education and knowledge about
the latest evidence-based CPGs for the prevention of primary CVD in at-risk patients is
essential. Doctor of nursing prepared practitioners must consider strategies to improve CPG
implementation for improved patient outcomes.
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Doctor of nursing practice prepared nurses are empowered to make change occur for
the betterment of their patients. These nurses must educate patients about risk factors for
primary CVD and its prevention. Patients should have a choice about whether they would like to
begin a new medication regimen once educated about mechanism of action, side effects, and
lifestyle changes. Doctor of nursing practice prepared practitioners in congruence with the
patient must provide effective and efficient care by using the latest EBP for the best patient
outcomes.
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2018. She was inducted into the Zeta Epsilon Chapter of the Sigma Theta Tau International
Honor Society in 2018. Sharnita is a member of the America Association of Critical Care
Nurses, Society of Nurses in Advanced Practice, Coalition of Advanced Practice Nurses of
Indiana, and the America Association of Nurse Practitioners. Sharnita is passionate about the
primary prevention of comorbidities and starting her business Voices and Visions of Hope, Inc.
which will help empower sexual assault survivors find their voice.
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ACRONYM LIST
ACC: American College of Cardiology
ACR: Albumin/Creatinine Ratio
ADA: American Diabetes Association
AHA: American Heart Association
ASCVD: Artherosclerotic cardiovascular disease
BMI: Body Mass Index
CDC: Centers for Disease Control
CDS: Clinical Decision Support
CDSS: Clinical Decision Support Systems
CHD: Coronary Heart Disease
CINHAL: Cumulative Index to Nursing and Allied Health Literature
CPG: Clinical Practice Guidelines
CVD: Cardiovascular Disease
DASH: Dietary Approaches to Stop Hypertension
DBP: Diastolic Blood Pressure
DNP: Doctor of Nursing Practice
EBP: Evidence-based Practice
EMR: Electronic Medical Record
FNP: Family Nurse Practitioners
GP: General Practitioner
HCP: Healthcare Providers
HDL: High-density Lipoprotein
HIPPA: Healthcare Insurance Portability and Accountability Act
3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor: statin
HTN: Hypertension
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IRB: Institutional Review Board
JBI: Joanna Briggs Institute
JHNEBP: Johns Hopkins Nursing Evidence Based Practice
JNC-8: 8th Joint National Committee
LDL-C: Low-density Lipoprotein Cholesterol
MeSH: Medical Subject Headings
NIHCE: National Institute for Health and Care Excellence
NHLBI: National, Heart, Lung and Blood Institute
PARiHS: Promoting Action on Research Implementation in Health Services Framework
PCE: Pooled Cohort Equation
PCP: Primary Care Physician
PICOT: Patient/Problem, Intervention, Comparison, Outcome, Time
PL: Project Leader
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-analyses
RCT: Randomized Control Trial
SBP: Systolic Blood Pressure
SI: Successful Implementation
SIGN: Scottish Intercollegiate Guidelines Network
T2DM: Diabetes Mellitus Type 2
USB: Universal Serial Bus
USPSTF: United States Preventive Services Task Force
WHO: World Health Organization
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Appendix A

Table 1A
Summary of the Evidence
Author(s),
Year,
Publication
Arditi, C.,
RegeWalther, M.,
Durieux, P., &
Burnand, B.
(2017).
Cochrane
Database of
Systematic
Reviews.

Fiks, A. G.,
Zhang, P.,
Localio, A. R.,
Khan, S.,
Grundmeier,
R. W.,
Karavite, D.

105

Purpose

Method

Setting/Sample

Design

To evaluate the
effects of
computergenerated
reminders
delivered to
HCPs on paper
improved on
quality of care
and patient
outcomes.

Literature
search of nine
databases,
Reference
checking
and citation
chasing

Sample:
35 studies which
focused on
healthcare
providers

Systematic
Review

Characterize
patterns of
adoption of the
clinical decision
support (CDS),
assess the
impact of

Reviewed 100
charts
Extracted

Setting:
Pediatric
physician offices

Prospective
Cohort study
and
Comparison
study

Sample:
16 practices
108 clinicians

105

Findings
Analysis
Computergenerated
reminders
delivered on
paper moderatecertainty slightly
improves quality
of care by 6.8%
in terms of
guideline
prevention and
disease
management
guideline
compliance.
Reminders alone
improved quality
of care by 11%.
Reminders with
other
interventions by
4%.
CDS system was
used 21% by
clinicians and
17% of eligible
otitis media visits.
Clinicians who
received

Level of Grade of
Evidence Evidence
II

A

I

A
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J.,…Forrest,
C. B. (2013).
Health
Research and
Educational
Trust
Flodgren, G.,
Hall, A. M.,
Goulding, L.,
Eccles, M. P.
Grimshaw, J.
M., Leng, G.
C., &
Shepperd, S.
(2016).
Cochrane
Database of
Systematic
Reviews
Hendrix, K.
S., Downs, S.
M., Carroll, A.
E. (2015).
Academic
Pediatrics.

performance
feedback on
adoption, and
measure the
impact of CDS
use on guideline
adherence.
Evaluated the
effects of
guideline
implementation
tools developed
by producers of
guidelines to
improve usage of
their guidelines.

Does yellow
highlighting
prompts in a
clinical decision
support system
improve the
responsiveness
of physicians.

41,391 visits

106
feedback
adhered to CPGs
increased 9.0%
compared to
others.

Systematic
review of
evidence from
several
database
searches

Sample:
Healthcare
professionals in
all 4 studies
Health system
mangers
Policy makers

Systematic
Review

Tools created by
guideline
producers
probably
improves
adherence and
implementation of
guidelines.

I

A

Physicians in
two offices
received
CDSS
generated
yellow
highlighted
prompts

Setting:
4 urban primary
care pediatrician
clinics

RCT

2237 randomized
prompts

I

A

2 offices
prompts were
not highlighted
when
presented to
physicians.

Sample:
7 prompts
included for
randomization
4 high-priority
non-randomized
prompts were
highlighted each
time

106

62% did not
respond to
highlighted
prompts
61% did not
respond to
prompts not
highlighted
There was not
statistical
difference in
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High priority
prompts were
always
highlighted

Ivers, N.,
Jamtvedt, G.,
Flottorp, S.,
Young, J. M.,
OdgaardJensen, J.,
French, S.
D.,…Oxman,
A. D. (2012).
Cochrane
Database of
Systematic
Reviews.
LI, Y. (2018).
Joanna
Briggs
Institute

To assess the
effects of audit
and feedback on
the practice of
healthcare
professionals
and patient
outcomes and to
examine factors
that may explain
variation in the
effectiveness of
audit and
feedback.
What is the best
available
evidence
regarding the
effectiveness of
audit and
feedback in
promoting
evidence
implementation?

107
responsiveness
of physicians
from highlighting
prompts or high
priority reminder
prompts and not
highlighting
prompts. (OR
1.056; 95% CI;
P= .259).

Literature
search of
several
databases

Sample:
140 Audit and
feedback RCTs

Searching the
literature and
databases for
systematic
reviews which
focused on
audit and
feedback.

N/A

Systematic
Review

Small
improvements in
professional
practice were
found with audit
and feedback.
Improvement
pertained to the
baseline
performance and
feedback was
provided.

I

A

Systematic
Review

After carefully
considering
practitioners audit
and feedback by
itself or cohabited
with other
strategies can
elicit change in
practice among
practitioners.

I

A

Healthcare
professionals
responsible for
patient care.
Postgraduate
healthcare
professionals
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Regan, M. E.
(2017).
Journal of
American
Association of
Nurse
Practitioners

Develop an
evidence-based
quality
improvement
intervention for
primary care
providers (PCP)
through the
delivery of
evidence-based
guidelines at
point-of-care.

An algorithm
and chronic
kidney disease
(CKD) tool was
developed in
the EMR
based on the
NKF-KDOQI
guidelines and
supporting
evidence.

Setting:
PCP offices
Sample:
11 PCP offices
80 PCPs
• 55
physicians
• 17 NPs
• 8 PA’s

Comparison
study

108
Survey’s: 19
PCP’s did not
take the pretest
and baseline
survey.
Knowledge:
increased
Lab diagnostic
(Z=-2.00, p=.046)
CKD stage
interpretation
(Z=-2.83, p=.005)

Preintervention:
Knowledge
surveys and
baseline data
was collected.
Chronic kidney
disease
educational
intervention
and tutorial on
clinical
decision
support tool
was presented
to participants
then sent via
email.

CKD patient
assessment (Z= 2.41, p=.024)
No significant
change between
CKD familiarity
scores (p > .05)

A go live
reminder email
was sent.

108

III

B
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Rokstad, I.,
S., Rokstad,
K. S.,
Holmen, S.,
Lehmann, S.,
Assmus, J.
(2013).
Scandinavian
Journal of
Primary
Health Care

Does
incorporating an
electronic
optional
guideline tool in
the standardized
referral template
used by general
practitioners
when referring
patients to
specialized care
could improve
outpatient
referral
appropriateness?

Electronic
optional
guideline tool
was created
for referral
Inclusion:
Sleep apnea
Chronic
obstructive
pulmonary
disease
Lung tumors of
the lung

Setting:
Bergen and the
Department of
Thoracic
Medicine at
Haukeland
University
Hospital

109

Intervention
Study

The intervention
yielded 1080 new
referrals of which
70% were from
GPs.
Time:
34% shorter in
the intervention
group – 82 used
of these used the
tool.

II

B

Systematic
Review

4.2%
improvement on
adherence to
computer
reminders
3.3% medication
ordering
3.8%
vaccinations
3.8% for testing

II

A

Sample:
210 general
practitioners (GP)
Intervention
group:
93 GPs
Control group:
117 GPs

Shojania, K.
G., Jennings,
A., Mayhew,
A., Ramsay,
C.R., Eccles,
M. P., &
Grimshaw, J.
(2009).
Cochrane
Database of
Systematic
Reviews.

To evaluate the
effects on
processes and
outcomes of care
attributable to
on-screen
computer
reminders
delivered to
clinicians at the
point of care.

Literature
search of
several
database and
bibliographies
of key articles.

Sample:
28 studies
RCT
Quasi-RCTs

Computergenerated
reminders at
point of care has
a small to modest
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110
improvement in
provider
behavior.

Zahanova, S.,
Tsouka, A.,
Palmert, M.
R., &
Mahmud, F.
(2017).
Canadian
Journal of
Diabetes.

Evaluate the
impact of a
computerized
point-of-care
decision support
system on
clinical practice
guideline
knowledge and
adherence.

iSCREEN
used as a
clinical
decision
support system
integrated into
the electronic
health record
as a reminder
to clinicians of
diabetic
patients.

Setting:
Diabetic clinic
Sample:
50 adolescents’
charts

Retrospective Surveys
study
collected: 58
Pre-intervention
31
Post-intervention
27
Questions
Knowledge:
Pre
Post-intervention
11%
improvement in
overall scores
(p=0.06)

Retrospective
chart review of
and
questionnaire
pre- and postimplementation

Utilizing current
resources:
5-point Likert
scale

A total of 50
charts was
reviewed (25
prior and 25
post iSCREEN
integration.

Nephropathy
(p=0.03) and
retinopathy
(p=0.04) initial
screening
increased and
under and over
screening
decreased.
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No change in
thyroid function
test screening or
dyslipidemia.
Appropriated
HTN screening at
baseline
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Appendix B

Clinical practice guideline flowsheet

Figure 4. Initiating Statin Therapy in Individuals Without Clinical ASCVD. Colors correspond to the Classes of Recommendation in
Table 1. *Fasting lipid panel preferred. In a nonfasting individual, a non–HDL-C level ≥220 mg/dL could indicate genetic
hypercholesterolemia that requires further evaluation or a secondary etiology. If nonfasting triglycerides are ≥500 mg/dL, a fasting
lipid panel is required. †The Pooled Cohort Equations can be used to estimate 10-year ASCVD risk in individuals with and without
diabetes. A downloadable spreadsheet enabling estimation of 10-year and lifetime risk for ASCVD and a Web-based calculator are
available at http://my.americanheart.org/cvriskcalculator and http://www.cardiosource.org/en/Science-And-Quality/PracticeGuidelines-and-Quality-Standards/2013-Prevention-Guideline-Tools.aspx. ‡For those in whom a risk assessment is uncertain,
consider factors such as primary LDL-C ≥160 mg/dL or other evidence of genetic hyperlipidemias; family history of premature
ASCVD with onset <55 years of age in a first-degree male relative or <65 years of age in a first-degree female relative, highsensitivity C-reactive protein ≥2 mg/L; CAC ≥300 Agatston units or ≥75th percentile for age, sex, and ethnicity (for additional
information, see http://www.mesa-nhlbi.org/CACReference.aspx); ABI <0.9; or lifetime risk of ASCVD. Additional factors that may
aid in individual risk assessment could be identified in the future. §1) Potential ASCVD risk-reduction benefits. The absolute
reduction in ASCVD events from moderate- or high-intensity statin therapy can be approximated by multiplying the estimated 10year ASCVD risk by the anticipated relative-risk reduction from the intensity of statin initiated (~30% for moderate-intensity statin or
~45% for high-intensity statin therapy). The net ASCVD risk-reduction benefit is estimated from the number of potential ASCVD
events prevented with a statin, compared to the number of potential excess adverse effects. 2) Potential adverse effects. The
excess risk of diabetes is the main consideration in ~0.1 excess cases per 100 individuals treated with a moderate-intensity statin
for 1 year and ~0.3 excess cases per 100 individuals treated with a high-intensity statin for 1 year. In RCTs, both statin-treated and
placebo-treated participants experienced the same rate of muscle symptoms. The actual rate of statin-related muscle symptoms in
the clinical population is unclear. Muscle symptoms attributed to statin therapy should be evaluated (see Table 8, Safety
Recommendation 8). ABI indicates ankle-brachial index; ALT, alanine transaminase; ASCVD, atherosclerotic cardiovascular
disease; CAC, coronary artery calcium; CK, creatine kinase; FH, familial hypercholesterolemia; LDL-C, low-density lipoprotein
cholesterol; MI, myocardial infarction; RCT, randomized controlled trial; and ULN, upper limit of normal.
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